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Protein-protein interactions are at the basis of many of the most important molecular 
processes in the cell, which explains the constantly growing interest within the 
scientific community for the structural characterization of protein complexes.1 
However, experimental knowledge of the 3D structure of the great majority of such 
complexes is missing, and this spurred their accurate prediction through molecular 
docking simulations, one of the major challenges in the field of structural 
computational biology and bioinformatics.2,3 
 
My PhD work aims to contribute to the field, by providing novel computational 
instruments and giving useful insight on specific case studies in the field. In 
particular, in the first part of my PhD thesis, I present novel methods I developed: i) 
for analysing and comparing the 3D structure of protein complexes, to immediately 
extract useful information on the interaction based on a contact map visualization 
(COCOMAPS4 web tool, Chapter 2), and ii) for analysing a set of multiple docking 
solutions, to single out the key inter-residue contacts and to distinguish native-like 
solutions from the incorrect ones (CONS-COCOMAPS5 web tool and CONS-RANK 
program, Chapter 3 and 4, respectively). 
In the second part of the thesis, these methods have been applied, in combination with 
classical state-of-art computational biology techniques, to predict and analyse the 
binding mode in real biological systems, related to particular diseases. This part of the 
work has been afforded in collaboration with experimental groups, to take advantage 
of specific biological information on the systems under study. In particular, the 
interaction between proteins involved in the autoimmune response in celiac disease6,7 
(Chapters 5 and 6) has been studied in collaboration with the group directed by Prof. 
Sblattero, University of Piemonte Orientale (Italy) and the group directed by Prof. 
Esposito, University of Salerno (Italy). In addition, recognition properties of the FXa 
enzymatic system8 has been studied through dynamic characterization of a FXa 
pathogenic mutant that causes problems in the blood coagulation cascade (Chapter 7). 
This study has been performed in collaboration with the group directed by Prof. De 
Cristofaro, Catholic University School of Medicine, Rome (Italy) and the group 
 9 
directed by Prof. Peyvandi, Ospedale Maggiore Policlinico and Università degli Studi 
di Milano (Italy). 
 
Finally, during my PhD I spent seven months in the groups of Prof. Charlotte Deane, 
Department of Statistics, University of Oxford (UK). During this period I studied the 
geometrical features of the proteins’ regions most recurrent in the protein-protein 
interaction, the loops, clarifying some structural aspects of them in one of the most 





Web tools and programs: 
 
COCOMAPS4 web tool freely available at: 
https://www.molnac.unisa.it/BioTools/cocomaps/ 
 
CONS-COCOMAPS5 web tool freely available at: 
https://www.molnac.unisa.it/BioTools/conscocomaps/ 
 
CONS-RANK program available upon request from the autors.  
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1.1 - Introduction to the protein-protein interaction 
 
Biological complexes: preliminary remarks 
The thousands of proteins expressed in the cells perform many of their functions 
through interactions with other proteins. The protein-protein interactions are intrinsic 
to every cellular process; in fact, protein complexes have been implicated as an 
essential component in the major research topics in biology and medicine, such as 
DNA replication, transcription, translation, splicing, secretion, cell cycle control, 
signal transduction, and intermediary metabolism.1,9 Therefore, the analysis at a 
molecular level of proteins in complexes is a matter of interest for biochemists, but 
also geneticists, cell biologists, developmental biologists, molecular biologists and 
biophysicists.10 
Protein-protein interactions play diverse roles and differ based on the composition, 
affinity, lifetime and nature of the association. In the permanent/obligate complexes 
the interactions are usually very stable and the interacting proteins are not found as 
stable structures on their own in vivo, while in the transient/non-obligate complexes 
there are transient interactions that associate and dissociate in vivo and the interacting 
proteins can also exist in the unbound form. Obligate complexes can be further 
divided into homodimers, i.e. interactions occurring between identical chains, 
heterodimers and multimers.11 It has been observed that different classes of 
association exhibit different physical and chemical properties in their interaction sites 
and different functions.12-14 So, for example, interactions in intracellular signaling are 
expected to be transient, since their function requires a ready association and 
dissociation, while an antigen-antibody interaction is generally permanent. Anyway, it 
is important to note that many protein-protein interactions do not fall into distinct 
types. Rather, a continuum exists between non-obligate and obligate interactions, and 
the stability of all complexes very much depends on the physiological conditions and 
the environment.11  
In the last years, experimental and theoretical work has been devoted to unravel the 
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principles of protein-protein interactions.15-20 
The formation of biological complexes is driven by the free energy of the complex 
(determined by physicochemical and geometrical interface properties) and the 
concentration of the protein components.11 The association of two proteins, in fact, 
relies on an encounter of the interacting surfaces, requiring co-localization in time and 
space. Generally a protein resides in a crowded environment with many potential 
binding partners with different surface properties; therefore, during the evolution the 
surfaces presumably evolve to optimize the interacting efficacy.21 When proteins 
collide, they do not diffuse away immediately (kinetic experimental evidence from 
Northup et al.22 and Wells23); instead, they are held loosely, rolling on one another 
and thereby sampling considerably more surface area than would be the case for a 
single elastic collision; this allows them time to become reorientated and 
repositionated on the surface or to adjust their shape to fit together more tightly 
(Figure 1).24 Recent studies are beginning to describe the dynamic of the assembly 
processes and to show that these non specific collisions producing transient 
‘encounter complexes’ play an important role in macromolecular associaction.25 The 
role of long-range forces in bringing molecules together has been studied from both 
experimental and theoretical viewpoints,26,27 suggesting the electrostatic interactions 
to be predominant.25 
 
Figure 1. Protein-protein interactions 
Equilibrium steps in a possible mechanism for protein–protein association. a) 
Formation of transient encounter complexes by nonspecific collisions, guided mostly 
by electrostatic interactions. b) Many encounter complexes separate rapidly. c) Some 
productive encounter complexes reorientate and come closer to the final, specific 
orientation, guided mostly by desolvation, as water molecules move away from the 




In this scenario, it is extremely valuable to obtain structural information for a 
complete understanding of both the biochemical nature of the process for which the 
components come together, and the facilitated design of compounds that might 
influence it. In particular, the structural characterization of a protein-protein interface 
includes the identification of interatomic hydrogen bonds, of salt bridges, of 
hydrophobic interactions, determination to the interaction surface area and possibly 
the presence of bridging water molecules28,29 The combination of all this information 
about the network of interactions defines the nature of the binding site and makes it 
possible to point out the residue-residue contacts with a key role in the interaction. 
Here below it is reported an example of a protein-protein interface characterization 
for the complex between the hemagglutinin (HA) and its antibody HC45.30 This 
antigen-antibody complex has a fundamental role in one of the most common world 
diseases: the influenza. Hemagglutinin, in fact, is the influenza virus glycoprotein that 
interacts with infectivity-neutralizing antibodies. It has a primary role in influenza 
infection mediating the binding of the virus to its cellular receptor. Over the years, 
amino acids substitution that arise by mutations in the genes for HA lead to escape of 
immune surveillance and recurrent epidemics - this process is called antigenic drift. 
So, the structural study of the complexes between HA and its antibodies is 
fundamental to understand the mechanism of the infection and to ensure the 
development vaccines of variants closely related to the circulating virus. Fleury at 
al.30 reported the structure of the X31 HA-HC45 Fab complex (PDB entry: 1QFU; 
resolution 2.8 Å), describing the atomic characteristics of their interactions (Figure 2). 
Upon complex formation, a surface area of 1.840 Å2 is buried; 36 amino acids 
participate in the intermolecular contacts, and 10 hydrogen bonds are established, 
involving antigen’s residues such as Asp36 and Arg94. The HC45 epitope, i.e. the 
antigen binding site, comprises in total 17 residues. It was also proved that the 
mutation Asp63Asn (Figure 2, right) leads to escape from neutralization by HC45, 




The X31 HA–HC45 Fab complex. Left: Ribbon diagram of the complex showing one 
HA monomer (the two domains HA1 and HA2 in blue and res, respectively) and the 
HC45 Fab (in green); the receptor binding site is shown in yellow. Right: Stick view 
of the HC45–HA interface (HA in blue, Fab in green). Of the 17 amino acids in the 
epitope, 12 are in the four polypeptide stretches of the HA1 chain (residues 59–63, 
78–79, 90–94 and 271–273) and are represented here. HA residues substituted in 
mutants with decreased affinity for the HC45 antibody (Asp63 and Arg94) are 
highlighted in cyan; their nitrogen and oxygen atoms are colored in cyan and red, 
respectively. Hydrogen bonds involving atoms of these HA residues are shown as 
dotted lines.30 
 
Structure of protein complexes 
As shown in the example, the structural characterization of biological complexes has 
a supreme significance in the study of the system and in all the possible 
pharmaceutical and medicinal applications,31 and although experimental methods for 
protein-structure determination have improved over the past decade, the number of 
structures for protein complex determined is still very little. Protein structures have 
been mainly achieved by two methods so far: X-ray crystallography and nuclear 
magnetic resonance (NMR). X-ray and NMR encounter difficulties to prepare 
complexes suitable for structural studies: by X-ray, the dynamics of the complex 
formation makes the crystallization difficult, while complexes of high molecular 
weight are difficult to deal with NMR.18,32,33  
Due to the greater difficulty in obtaining suitable protein-protein complexes for the 
experimental determination, there is relatively little structural information available 
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about them compared to the proteins that exist as single chains or form permanent 
oligomers.33 Hence, experimental studies are faced with outstanding technical 
difficulties and the number of solved complexes deposited in the Protein Data Bank34 
(PDB: www.rcsb.org/pdb) is still orders of magnitude smaller than structures of 




Number of X-ray structures of protein-protein complexes (in green) and single chain 
proteins (in blues) deposited in the wwPDB34 within October 2011. 
 
Despite this disproportion, the growing number of available experimental structures 
for protein-protein complexes in the years has allowed a statistical study of the 
properties and the chemical-physical forces that regulate protein-protein interactions 
(hydrophobicity, hydrogen bonding, electrostatic interactions, van der Waals 
interactions, and so on), that are useful information in the development of 
computational strategies helping in the structural prediction and characterization.35 In 
fact, notwithstanding the practical difficulties, for a better understanding of the 
biological function of a protein, knowledge of its three-dimensional structure is 
fundamental. Therefore, it would be quite rewarding to have efficient and reliable 
computational algorithms available to predict correctly conformations of protein 
complexes based on the structures of the free molecules. Indeed, in the past two 
decades there was an emergence of a large variety of theoretical algorithms designed 
to predict the structures of protein-protein and protein-ligand complexes: a procedure 
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named molecular docking.36 
Interest in protein docking is growing within the scientific community, and many 
interdisciplinary approaches are being applied to model, predict, and understand 




1.2 - Approaches to the docking problem 
The docking technique has the task of assembling two separate protein components 
(as the ones seen in Figure 4a and Figure 4b) into their biologically relevant complex 
structure (Figure 4c), giving a model of the way the two proteins bind each other.38,39 
Computational docking, if accurate and reliable, can therefore play an important role, 
both to infer functional properties and to guide new experiments. So, due to its 
potential applications in generating models of molecular complexes, it has attracted a 




Figure 4. Schematic representation of the protein-protein docking technique 
X-ray structure of (a) FAB Hyhel63 antibody (PDBID: 1DQQ), (b) HEW lysozyme 






The docking in general, and the protein-protein docking in particular, is not a simple 
problem. The objective of it is to predict the three-dimensional arrangement of a 
protein-protein complex from the coordinates of its component molecules, hopefully 
pointing out most of the residue-residue contacts involved in the interaction.41-47 
There are no general rules to predict a binding interface. Basically, all docking 
approaches assume that the native complex is near the global minimum of the energy 
landscape. In fact, based on thermodynamic hypothesis, at fixed temperature and 
pressure the Gibbs free energy of the macromolecule-solvent system reaches its 
global minimum at the native state of the complex.48 It has been established over the 
last two decades that the energy landscape of a foldable protein resembles a many-
dimensional funnel with a free energy gradient toward the native structure (Figure 
5).21,49,50 A number of studies suggest that the landscape theory also applies to 
protein-protein association.51-54 This theory states that the assembly of two proteins is 
initiated by the formation of nonspecific encounter complexes,24 followed by 
rearrangements of them driven by stronger and more specific interactions. Taking into 
account that it is the structural features that determine if two proteins interact,55 then 
such hypothesis implies that not only the ‘final’ binding but also other parts of the 
surface contain information for interacting with the partner. The size of the funnel 
will be determined by the length scales of the long-range electrostatic and 
hydrophobic interactions and the geometry of the proteins, and hence the funnel is 
restricted to a neighborhood of the native complex.56 There is a free energy gradient 
toward the native state, but the funnel is rough, giving rise to many local minima.21,57  
 
Figure 5. Protein-protein complex energy landscape 
The many-dimensional funnel representing the energy landscape of a protein-protein 
complex. With “N” the native conformation is indicated.  
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Therefore, all the current docking methods are based on the optimization of a function 
approximating the free energy of the complex. 
In all the docking algorithms, there are two crucial steps to generate possible models 
of the three-dimensional arrangement of a complex:  
 
1. Searching (low-resolution search), consisting in the generation of thousands 
of alternative poses (decoys) to sample the rotational/translational space; 
 
2. scoring and ranking (high-resolution refinement), consisting in scoring these 
poses using a ‘pseudo-energy’ function in order to rank the poses and so to 
identify the native-like solutions. 
 
A simple docking algorithm may fail predicting the native complex. Anyway, a recent 
work58 shows that the docking technique is able to distinguish between binding and 
non-binding partners, based on their score distributions. This may indicate that 
although protein surface morphology is not enough to find the native interface, it at 
least contains sufficient information to identify a ‘bona fide’ interactor.58 
Anyway, it has been shown in CAPRI that, whereas approximately correct solutions 
are generated by the first step of the docking, scoring functions unfortunately often 
fail to correctly rank them.58,59 
 
Step 1: sampling the conformational space 
The searching step involves an exhaustive search of the conformational space of one 
protein with respect to the other, resulting in a six-dimensional search (6D). The 
search of through the entire conformational space of the complex geometry makes the 
calculation expensive, so it is necessary to simplify the system preserving the 
geometrical and physicochemical properties of the atoms, using mathematical models, 
such as geometrical shape descriptors or a grid.42 Once having the easier 
representation of the system, almost all the docking programs use the same approach 
for the searching step: one protein is fixed in space (usually the bigger one) and the 
second one is rotated and translated around the first one. To minimize the degrees of 
freedom, both molecules are treated as rigid bodies, but still a simple systematic 
search is usually impracticable because the searching algorithm entails evaluating in 
the order of billions (109) distinct possibilities.60 
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Although geometric complementarity of the protein surface is the filtering criterion 
most commonly used to eliminate a large number of solutions with poor surface 
matching,47 the docking problem is not simply matching two irregular shapes, but 
there are also other geometric, electrostatic or hydrophobic factors to take into 
account.61  
So, there are a lots of possible search methods that have been used in protein-protein 
docking programs. Most methods that perform well in CAPRI are based only on three 
approaches. Some programs use grid-based spatial searches that are sped up with a 
Fast Fourier Transform (FFT), a method first applied in 1992 by Katchalski-Katzir 
and co-workers.62 The other approaches for docking searches include instead Monte 
Carlo based searching63,64 and geometric hashing.65 
 
Step2: scoring and ranking docking decoys 
The initial stage, which treats proteins as rigid bodies and generates many prediction 
(10.000 or more), is followed by the refinement stage, which performs any 
combination of detailed scoring, energy minimization, side chain optimization to the 
aim of valuate the energies of protein-protein docking poses in order to identify the 
one with the lowest energy as the predicted binding mode.47  
A fundamental point of any docking method is to be computationally efficient, having 
a scoring scheme able to evaluate a huge number of solutions and discriminate the 
native-like binding modes from the wrong decoy complex structures in a reasonable 
computational time.42  
The free energy of binding, ΔGbinding, is not easily accessible but other and faster 
scoring functions that model ΔGbinding as accurately as possible, i.e. provide good 
correlations with experimental binding affinities, can be used.60 Considering the 
energy function as a funnel-like function, as described above, the original free energy 
function is extremely rugged with huge number of local minima even in a small 
region of conformational space. Yet its approximated scoring function is much 
smoother and still capture the overall funnel-like landscape, which provides an easier 
free energy minimization (see Figure 6).66 Further, according to the general idea of 
the funnel-shaped binding energy, there are an ensemble of encounter complexes 
from which the binding process initiates and precedes, that follow different pathways 
to converge in native state defined by the global minimum. So, there are many 
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possible routes for downhill in the binding funnel, and these are determined by 




The schematic representation of a funnel-like function (dark line) and an 
approximated scoring function (dotted line), still catching some of the local minima 
(indicated as small squares). 
 
Whether this ensemble of orientations reflects the true binding-energy landscape will 
depend on the accuracy of the energy description and the efficiency of the sampling 
method. Most of the docking algorithms developed so far use the extent of geometric 
complementarity of the protein surfaces because it is a fast filter to eliminate a large 
number of solutions with poor surface matching. It is, however, usually recognized 
that a criterion based exclusively on geometric complementarity is far from being 
enough to distinguish among native and non-native docked geometries, except for a 
very a small number of cases.67 Numerous criteria have been implemented with 
different levels of success: steric complementarity of the shapes of the interaction 
sites, electrostatic interactions, hydrogen bonding, van der Waals, pair potential, 
desolvation, rotamer probabilities, contact pair potential and knowledge-based 
potentials. Different docking programs can use different combinations of these terms 
in a weighted sum. Furthermore, exclusion of the solvent from the interface and the 
associated solvent entropy change play an important role in the stabilization of protein 
interactions, and can be estimated from empirical potentials or database derived 
functions.18,68  
 
Finally, the scoring part is generally followed by a final post-processing stage, in 
which a large number of low energy conformations (usually 2000 to 20000) are 
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retained and ranked. A common way to rank the retained decoys is clustering them 
using pairwise root mean square deviation (RMSD, a number that quantifies the 
structural diversity between two structures) as the distance measure, and then ranks 
the clusters according to their size, i.e., identifying conformations that have large 
numbers of neighbors.56,57 The method is based on the observation that, in the free 
energy landscapes of partially solvated receptor-ligand complexes, the free energy 
attractor at the binding site generally has the greatest breadth among all local 
minima.69 Hence, following the uniform sampling of the conformational space 
defined by translations and rotations of the ligand, the docked conformations that are 




Although important progresses, protein-protein docking remains a quite difficult 
procedure, due to the complex nature of the problem it tries to solve. One of the most 
useful approach to improve the quality of the docking simulations is the use of 
biological information about the complex interface to confine the search of allowed 
configurations or filter out wrong solutions.42,70 Biological information available from 
experiments or from computational methods on the regions or residues likely involved 
in the interaction are one of the key points for the improvement of a docking 
simulation. Almost all the docking programs have a section in which it is possible to 
exclude regions not involved in the interaction, or driving the docking towards the 
ones involved (for example, the software HADDOCK32 dedicate a section to express 
the NMR data such as chemical shift perturbation and residual dipolar couplings in 
terms of ambiguous interactions restrains). If experimental data are not available for 
the protein-protein system that is simulated, it is also very helpful to carry out 
structural comparisons of the same protein family.42,70 Fox example, the binding 
crevice centered on the catalytic triad of serine proteases (His, Asp, Ser)71,72 (see 
Chapter 7), as well as the complementarity defining regions of immunoglobulins 
(CDRs), which are part of the biological surface involved in the interaction with 
protein interactors (see Chapter 5 and Chapter 6), are both well characterized; 
although in general, a protease-inihibitor interface is more static and consequently 
more easily predicted than an antibody-antigen interface.73 
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1.3 - The CAPRI experiment: what is the state of protein-protein 
docking 
As described above, protein-protein docking procedure is a very helpful method to 
model biological complexes and to guide biochemical experiments. A general 
docking algorithm can be briefly described as an initial searching step yields a long 
list of candidate structures; the following step requires some forms of post-processing, 
which may include: i) scoring or re-scoring of the docked conformations using a more 
accurate energy function, or ii) refining the conformations followed by re-scoring.74 
These treatments usually improve the number of near-native conformations among 
the 10 to 100 lowest energy structures, but in most cases are unable to eliminate all 




The stages of protein-protein docking.  
 
A variety of approaches have been used in docking programs that mostly differ in the 
stages of the algorithms, showing different performances depending on the approach 
and the nature of the biological system. In this scenario, the comparison of different 
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docking programs to establish their relative performances is very important. Indeed, it 
is required an objective valuation of the model quality. To this aim, the international 
Critical Assessment of Prediction of Interactions (CAPRI) experiment was designed, 
precisely to evaluate current computational approaches of protein–protein docking.75 
The CAPRI is a community-wide experiment designed according to the model of the 
Critical Assessment of Techniques for Protein Structure Prediction (CASP).76 It was 
designed in June 2001 at the Conference on Modeling Protein Interactions in 
Genomes organized in Charleston, SC, by Ilya Vakser (Medical University of South 
Carolina) and Sandor Vajda (Boston University). CAPRI targets are protein–protein 
complexes and it is data-driven, meaning that it can start whenever an experimentalist 
offers an adequate target and ends 6–8 weeks later with the submission of predicted 
structures.76-78 Computational researchers are given the three-dimensional coordinates 
of the unbound structures for a given target before the experimental structure of the 
complex is published. The researchers are then given a few weeks to dock the two 
structures together, possibly using biological information and literature searches. 
Therefore, CAPRI challenge provides the docking community with a unique blind 
setting of simultaneously assessing of all docking algorithms, and has led to 
significant advances in the field.79,80 
 
From the analysis of CAPRI results, it can be noted that there are some docking 
programs that give globally better predictions, such as ICM,81 ZDOCK,79 
HADDOCK,32 RosettaDock,64,82 ClusPro56 and Camacho group’s Smooth-Dock.75 
Furthermore, in Figure 8, the number of citations per year of the most common 
docking programs joining to CAPRI is plotted (references took from ISI Web). From 
the plot it is possible to observe that only after 2003 there was an increase of the 
number of citations of the protein–protein docking software. Since their publication 
the most cited programs are HADDOCK,32 RosettaDock,64 three-dimensional-Dock,83 
BIGGER,67 and Dot.53 It is possible to observe an increase of the number of citations 
per year of the Patch-Dock,44,45 ClusPro,56 HADDOCK,32 RosettaDock64 and 
ZDOCK.79 When considering only papers that apply the different software to specific 
biological problems (represented in Figure 8b) HADDOCK results to be the most 






Number of citations per year of the docking programs described earlier. Data taken 
from ISI Web of Science (February of 2007).; only the articles with experimental 
predictions were considered. 
 
Four of the most common docking programs are RosettaDock,64 ZDOCK,79 
HADDOCK32 and ClusPro.56 The advantage of RosettaDock compared with the other 
three programs is the close correspondence of the lowest free energy structures with 
the X-ray complex, the disadvantage is that using a Monte Carlo technique in the 
searching step and a detailed energy function, it is quite slower than the others. 
Instead, ZDOCK is a FFT based algorithm, so it is faster but it does not perform well 
in the cases of complexes with large conformational change. HADDOCK seems 
combine the rapidity with the fact that the both side chains and backbone are allowed 
to move, and this increase the accuracy of the scoring if compared with classical rigid 
body docking programs. The big disadvantage in HADDOCK is that it is data-driven, 
so its performance closly depends on the availability and the level of confidence of 
experimental information. Compared with the other programs, ClusPro has the 
advantage to be a fully automated algorithm that rapidly docks, filters and ranks 
potential models within a short amount of time, using only the structures of the 
component proteins, and eventually adding experimental data if available.  
A more detailed description of these methods is reported in the Appendix 2.  
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1.4 - The PhD project 
My PhD work has been focused on the study of protein-protein interactions, taking 
advantage of computational techniques. The study has been devoted to two main 
aspects: i) the development of new methods to analyse and rank docking solutions 
(Chapters 2,3,4), and ii) the application of these methods, in combination with 
classical state-of-art computational biology simulations, to predict and analyse the 
binding mode in real biological systems, which are related to particular diseases 
(Chapters 5,6,7). As availability of biological information is guarantee of a better 
success rate in the docking simulations, we afforded the latter part of the work in 
collaboration with experimental groups. In particular, interaction between proteins 
involved in the autoimmune response in celiac disease has been studied in 
collaboration with the group directed by Prof. Daniele Sblattero, University of 
Piemonte Orientale (Italy) and the group directed by Prof. Carla Esposito, University 
of Salerno (Italy). In addition, recognition properties of the FXa enzymatic system has 
been studied through dynamic characterization of a FXa pathogenic mutant that 
causes problem in the process of blood coagulation. This study has been performed in 
collaboration with the group directed by Prof. Raimondo De Cristofaro, Catholic 
University School of Medicine, Rome (Italy) and the group directed by Prof. Flora 
Peyvandi, Ospedale Maggiore Policlinico and Università degli Studi di Milano (Italy). 
 
Finally, during my PhD I spent seven months in the groups of the Prof. Charlotte 
Deane, Department of Statistics, University of Oxford (UK). In that period, I studied 
the geometrical features of the proteins’ regions most recurrent in the protein-protein 
interaction, the loops, clarifying some structural aspects of them in one of the most 




CHAPTER 2 - COCOMAPS: a web tool for analyzing, 
visualizing and comparing the interface in protein-protein 
and protein-nucleic acid complexes 
 
 
2.1 - Introduction 
Interaction between biomolecules is at the basis of many of the most important 
molecular processes in the cell. As described in Chapter 1, protein-protein interactions 
underlie for instance signaling, regulation, immunogenic recognition, whereas 
protein-nucleic acid interactions under- lie processes such as DNA transcription, 
repair, replication, as well as post-transcriptional events, including RNA splicing and 
editing. 
Availability of a 3D structure for a complex allows detailed analysis of the interaction 
at atomic level between the molecular partners, which is a fundamental step for 
possible biomedical and biotechnological applications. Moreover, the recent 
development of well performing docking software (see Chapter 1 and Appendix 2) to 
predict the 3D structure of macromolecular complexes requires, in the analysis step, 
the accurate and tedious screening of all the best solutions. It is indeed well accepted 
that the correct solution, if any, can be found within the 10-20 best ranked ones (e.g. 
the CAPRI assessment accepts 10 different models per target from each predictor). 
It is therefore of timely interest, both for bioinformaticians and wet biologists, to have 
programs and tools able to automatically analyse features of a complex interface, and 
to easily and intuitively discriminate between similar and different binding solutions 
Several valuable web tools have been made available for the analysis of the interface 
in biomolecular complexes.84-92 However, no available web tool has been 
implemented to provide interactive contact maps from the 3D structure of a 
biomolecular complex. 
Introduced to provide a reduced representation of a protein structure, contact maps 
have been successfully exploited for describing similarity between protein structures. 
Analogously, an intermolecular contact map between two or more interacting 
molecules could identify uniquely and intuitively the surface of interaction, 
representing a sort of fingerprint of the complex and reporting the crucial information 
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in a ready-to-read form. Interesting work has in fact been done to demonstrate the 
advantages of using contact map representations for the alignment of protein-protein 
interfaces.93,94 
For this reason, during my PhD study my groups and I have implemented 
COCOMAPS (bioCOmplex Contact MAPS).4 It is a novel web tool to easily and 
effectively analyse and visualize the interface in biological complexes, such as 
protein-protein, protein-DNA and protein-RNA complexes, by making use of 
intermolecular contact maps.  
 
 
2.2 - Methods 
All the programs under COCOMAPS have been written in python, taking advantage 




2.3 - Results and Discussion 
Description of the tool 
The tool takes in input the PDB type file of the complex, that contains the Cartesian 
coordinates of the complex. Usually, the two interacting parts of the complex are 
distinguished by different names of the chains, indicate by a single letter. In fact, a 
user-friendly interface of the tool allows to download input files directly from the data 
bank wwPDB95 (for the experimental structures) or to upload locally stored PDB 
formatted files. The user is requested to specify the chain identifiers for the molecules 
involved in the interaction to be analyzed. More chains can be selected for each 
interacting partner, which overcomes a limitation of the other available tools that 
either work on all the chains present in a PDB file, or on one pair of them at a time. 
Therefore, COCOMAPS can be used to analyze the interface between two molecules, 
between one molecule and an ensemble (made by two or more molecular chains) or 
between two ensemble, depending on how many chains are specified.  
COCOMAPS outputs are displayed on the results HTML page for one month and 
archived as downloadable compressed files. A link to the online resource is also 
emailed to the user, if requested.  
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COCOMAPS provides three graphical contact maps defining the interface of the 
complex: 
 
1. Black and white contact map; 
2. Distange range contact map; 
3. Properties contact map. 
 
 The first one is a classical intermolecular contact map (Figure 9, a) where a black dot 
is present at the crossover of residues i and j, belonging to molecule/assembly 1 and 
molecule/assembly 2, respectively, if any pair of atoms belonging to the two residues 
is closer than a cut-off distance chosen by the user (default value being 8 Å). The 
second map (Figure 9, b), named “distance range contact map”, reports in different 
colors inter-residues contacts at increasing distances. Red, yellow, green and blue 
indicate contacts within 7 Å, 10 Å, 13 Å and 16 Å, respectively. The third contact 
map (Figure 9, c), named “properties contact map”, is similar to the first one, but 
each contact is colored according to the physico-chemical nature of the two 
interacting residues: hydrophobic-hydrophobic in green, hydrophilic-hydrophilic in 
violet and hydrophobic-hydrophilic in yellow. 
By mousing over the maps, it is possible to visualize the identity of the residues pairs 
corresponding to the dots. 
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Figure 9.  
A sample of COCOMAPS contact maps for the complex Ibalizumab antibody 
(chains L and H) with the CD4 antigen (chain A), PDBcode: 3O2D. a) Black and 
white contact map; b) Distance range contact map; c) Properties contact map. 
 
Our tool also provided detailed information, organized in table (Figure 10, a and b), 
about: 
 
1) interacting residues, defined on the basis of a cut-off distance that can be 
customized by the user; 
2)  residues at the interface, defined on the basis of the buried surface upon 
complex formation; 
3) intermolecular H-bonds, with specification of the acceptor and donor atoms.  
 
A 3D visualization of the complex in JMol (http://www.jmol.org) (Figure 10, c) is 
also provided online, with the interacting residues highlighted. Finally, a ready-to-run 
Pymol96 script, which generates a visualization of the interface in the corresponding 
3D-structure, is downloadable. Accessible surfaces and H-bonds are calculated by 
NACCESS97 and HBPLUS,98 respectively. 
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All the programs under the COCOMAPS web tool have been written in python, 
taking advantage of python libraries such as SciPy and Matplotlib. 
 
 
Figure 10.  
Sample COCOMAPS outputs for the complex Ibalizumab antibody (chains L and H) 
with the CD4 antigen (chain A), PDBcode: 3O2D. a) First part of the table of 
interacting residues, defined on the basis of the cut-off distance; b) Overview table of 




Although COCOMAPS provides a complete characterization of the interfaces in 
biological complexes, the real novelty that we have introduced is the generation of 
intermolecular contact maps. Contact maps give an immediate view of which regions 
of the two partners are in contact.  From the properties map, it is also possible to 
immediately appreciate the physico-chemical nature of the interaction.  
As an example, in Figure 11 properties contact maps are reported for the biological 
complexes of the antigen hen egg lysozyme (HEL) with two different antibodies, 
namely D1.3 (PDBcode: 1VFB)99 and F10.6.6 (PDBcode: 1P2C)100, together with the 
corresponding Pymol 3D representation of the complexes, as generated by 
COCOMAPS.  
The 2D contact-maps of the HEL-antibody complexes reported in Figure 11 show in a 
glance that the two binding solutions are completely alternative, and the 
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corresponding epitopes present no overlap. In addition, contact maps specify which 
regions of the antibodies and of the antigen are in contact.  
As expected, both the antibodies contact HEL with their six hypervariable loops (L1, 
L2, L3, H1, H2 and H3, also labeled in the figure, for the sake of clarity). As for the 
HEL antigen, it contacts the D1.3 antibody with about 30 N- and 30 C-terminal 
residues and the F10.6.6 antibody with its central region (residues 40-85). The same 
information could of course be extracted either from lists of interacting residues or 
from the 3D view of the complexes (such as that in Figure 11). However, differently 
from the contact-map view, which is immediate, in both of the above cases, manual 
intervention by the user would be required to extract the needed information. Further, 
the contact maps in Figure 11 immediately indicate that the H3 loop of the D1.3 
antibody is more involved in the interaction with HEL than the F10.6.6 H3 loop, and 
that it mostly gives hydrophilic-hydrophilic contacts (magenta dots). This is a 
consequence of the D1.3 H3 loop amino-acids sequence, (one code amino-acids 
sequence: ERDYRLDY), which is longer than the F10.6.6 one (one code amino-acids 





Figure 11.  
Comparison of the complexes of HEL with two different antibodies: D1.3 (PDBcode: 
1VFB) and F10.6.6 (PDBcode: 1P2C). Left: COCOMAPS “properties contact maps”. 
Labels have been added for the antibody hypervariable loops L1-L3 and H1-H3. 
Magenta, green and yellow dots indicate hydrophilic-hydrophilic, hydrophobic-
hydrophobic and hydrophobic-hydrophilic contacts, respectively. The cut-off distance 
is set to 10 Ǻ. Right: A Pymol visualization of the complexes based on the automatic 
COCOMAPS script .pml; residues at the interface are shown as "sticks". 
 
 
2.4 - Conclusion 
In conclusion, this first study has been focused on the development of a tools able to 
automatically analyze, visualize and compare the interfaces both in experimental and 
predicted 3D structures of protein-protein and protein-nucleic acids complexes. 
COCOMAPS combines in a single tool the traditional analysis and 3D visualization 
of interfaces in biocomplexes with the effectiveness of the contact map view. It can 
straightforwardly be applied to the analysis of interfaces both in experimental and 
predicted 3D structures of biological complexes.  
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CHAPTER 3 - CONS-COCOMAPS: a novel web tool to 
measure and visualize the conservation of inter-residue 
contact in multiple docking solutions 
 
 
3.1 - Introduction 
As described in Chapter 1, most important molecular processes in the cell rely on the 
interaction between biomolecules. Understanding the molecular basis of the 
recognition in a functional biological complex is thus a fundamental step for possible 
biomedical and biotechnological applications. However, the 3D structure of a 
significant fraction of biomolecular complexes is difficult to solve experimentally. In 
this scenario, the development of accurate protein-protein docking programs is 
making this kind of simulations an effective tool to predict the 3D structure and the 
surface of interaction between the molecular partners in macromolecular 
complexes.101 Unfortunately, correctly scoring the obtained solutions to extract 
native-like ones is still an open problem 95,102, which is recently also object of 
assessment in CAPRI (Critical Assessment of PRedicted Interactions), a community-
wide blind docking experiment 59. As a consequence, the confidence to have a near-
native solution among the ten best ranked ones is still an unreached task 102. This 
requires the accurate and tedious screening of many docking models in the analysis 
step.  
Typically, as described in Chapter 1 and Appendix 2, the first step of a docking 
simulation generates a large number, around 105-106, of 3D models (decoys). Such 
decoys are then clusterized on the basis of RMSD values, usually calculated on the 
atoms of the smaller molecular partner (or “ligand”) 56,64,103. The different solutions 
are ranked according to the cluster population: the most populated the cluster, the 
higher the rank. However, RMSD has two major limitations: i) its statistical 
significance is length dependent and ii) it is a global metric, that may not be able to 
characterize local similarities. As a consequence, solutions belonging to different 
RMSD-based clusters may share a notable number of intermolecular contacts, 
pointing essentially to the same interface. Therefore, as already reported 50,102,104,105, 
RMSD cannot be the only descriptor for the similarity of multiple docking solutions. 
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Indeed, in the CAPRI experiment the correctness of a prediction, i.e. its similarity to 
the native structure, is assessed not only by means of RMSD based criteria, but also 
from the conservation of ligand-receptor contacts, as compared to the native structure 
50. Alternative scores have also been proposed to evaluate the correctness of a docking 
prediction, based on the geometric distance between the interfaces, and the residue-
residue contact similarity 104.  
However, the normal case in real-life research is having many different docking 
solutions to analyse and obviously no native structure to compare them to. Therefore, 
it would be of great utility both for bioinformaticians and wet biologists to have 
programs and tools to easily and effectively analyse and compare multiple docking 
solutions, based on criteria other than ‘simple’ RMSD. Most of all, it would be useful 
to visualize the consensus of multiple docking solutions, in order to appreciate at a 
glance which is the conservation rate of the predicted interface and which are the 
residues most often predicted as interacting.  
As a matter of fact, if different docking solutions, especially from a series of well 
recognized programs, point to the same interacting regions, it is likely that the 
prediction can be better trusted. Consequently, it will be reasonable to focus attention, 
as for instance in site-directed mutagenesis experiments, on the residues most 
frequently predicted to be involved in the interaction. The concept of “consensus” has 
indeed been widely demonstrated to improve the performance of bioinformatics tools 
in many fields, including the prediction of protein and RNA secondary structure 106-
112, of membrane protein topology 113, of protein retention in bacterial membrane 114, 
of docking small ligands to proteins 115,116, etc. Recently, consensus interface 
prediction has also been used to improve the performance of macromolecular docking 
simulations 117-119.  
However, although many valuable tools have been made available to analyse the 
interface in biomolecular complexes 4,84-88,90-92, no tool has been developed to the aim 
of measuring and visualizing the consensus of multiple docking solutions. In Chapter 
2 there is the description of COCOMAPS (bioCOmplexes COntact MAPS, available 
at the URL 90), a comprehensive tool that my group and I developed to analyse and 
visualize the interface in biological complexes, by making use of intermolecular 
contact maps 4. We have shown that intermolecular contact maps can be very 
effective in providing an immediate 2D-view of the interaction, allowing to easily 
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discriminate between similar and different binding solutions. They represent a sort of 
fingerprint of the complex, providing the crucial information in a ready-to-read form. 
Then, we used intermolecular contact maps to develop the second novel tool, CONS-
COCOMAPS (CONSensus-COCOMAPS), to measure and visualize the conservation 
of inter-residue contacts in multiple docking solutions. CONS-COCOMAPS provides 
both numerical values of the contacts conservation and a graphical representation in 
the form of a “consensus map”. To show its performance, here we applied CONS-
COCOMAPS to the analysis and visualization of a few test cases taken from recent 
CAPRI rounds.  
 
 
3.2 - Methods 
Given an ensemble of N models of the same biomolecular complex, the pairwise 
contacts conservation score, 
ij
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where nci and ncj are the total number of inter-residue contacts in models i and j, 
respectively, and ncij is the total number of inter-residue contacts common to models i 
and j. Following this definition, the average pairwise contacts conservation score 
av
pairC  simply is the value of 
ij
pairC  averaged over all the possible pairs of models in 
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However, Eq 1. can be generalized to a conservation score defined over all the N 












where nc100 is the total number of inter-residue contacts common to all (100%) the 
models in the ensemble. The contacts conservation score of Eq. 3 can be extended to 
measure any amount of inter-residue contacts common to a given percentage of 
analysed models. For instance, C70 is calculated as in Eq. 4, where nc70 is the total 











The total number of inter-residue contacts in an ensemble of N models, Nt, is 





incNt . (5) 
 
Finally, on a residue level we define the conservation rate, CRkl, of Eq. 6, where nckl 
is the total number of models where residues k and l are in contact. 
 
N
ncCR klkl = . (6) 
 
Within this work, two residues are defined in contact if any pair of atoms belonging to 
the two residues is closer than a cut-off distance of 5 Å, which is the threshold 
distance adopted in the assessment of CAPRI predictions to define native residue-
residue contacts 50. Conservation rates can be plotted in the form of consensus contact 
maps, which are depicted in a grey scale. The highest conservation corresponds to a 
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black dot, absence of conservation corresponds to white, and contacts at increasing 
conservation appear in darker grey.  
All the programs under CONS-COCOMAPS have been written in python, taking 
advantage of python libraries such as SciPy and Matplotlib. It is freely available as a 
web tool at the URL 92). 
3.3. CAPRI models 
The docking models for recent CAPRI targets were downloaded from the official web 
site (at the URL 88). We selected seven recent protein-protein targets (T24-T26, T28-
T29, T32, T36) for which the docking models were made available to the public. Four 
of them, T25, T26, T29 and T32, have at least one medium quality prediction and are 
more extensively discussed in the text. A total of 2130 CAPRI models have been 
analysed, 300 for target T24, round 9, 300 for target 25, round 9, 310 for target 26, 
round 10, 320 for target 28, round 12, 350 for target 29, round 13, 350 for target 32, 
round 15, and 200 for target 36, round 15 (see Table 1). Note that targets T24 and T25 
refer to the same native complex. The quality score (Q-score) for each Predictor was 
calculated by summing 0, 1, 2 and 3 for each incorrect, acceptable, medium quality 
and high quality solution, respectively, as assessed in CAPRI 59. Predictors which 
submitted less than the ten allowed models and those who submitted models with a 
ligand and/or receptor sequence not corresponding to the target were excluded from 
the analysis. L_rmsd is the pair-wise RMSD calculated on all the heavy atoms of the 
ligand after a LSQ RMS fit of the receptor invariant residues backbone, as in the 










T24 R 09 296 4 0 0 300 
T25 R 09 268 19 12 1 300 
T26 R 10 276 19 15 0 310 
T28 R 12 320 0 0 0 320 
T29 R 13 333 8 9 0 350 
T32 R 15 316 6 13 15 350 
T36 R 15 199 1 0 0 200 
 
Table 1. Analysed models 
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3.4 - Results and Discussion  
Given a number of multiple docking solutions, we calculated the conservation score 
of the inter-residue contacts at different percentages, from 0 to 100%. For instance, 
C70 gives the amount of inter-residue contacts which are conserved in 70% of the 
compared models. When only two models are compared, the pair-wise conservation 
score, 
ij
pairC , is calculated. CONS-COCOMAPS then plots the inter-residue contacts 
conservation to an intermolecular contact map, that we call “consensus map”.  
The conservation of inter-residue contacts has been here measured and visualized 
with CONS-COCOMAPS for a total of 2130 models submitted to CAPRI for seven 
different targets: T24, T25, T26, T28, T29, T32 and T36 (see Table 1). The 
percentage of correct solutions among those submitted is 10-11% for T25, T26 and 
T32 and 5% for T29. For the remaining targets, T24, T28 and T36, it is instead much 
lower: 1% and 0% and 0.5%, respectively (see Table 1). 
 
 Inter-residue conservation versus L_rmsd 
The pair-wise conservation score, 
ij
pairC , between all the models within each of the 
CAPRI targets T25, T26, T29 and T32 have been plotted versus the corresponding 
L_rmsd values in Figure 12. As expected, 
ij
pairC  rapidly decreases as the L_rmsd 
increases, with 
ij
pairC  approaching to zero at L_rmsd higher than 30-40 Å. The 
ij
pairC  
distribution is significantly spread out, even at 
ij
pairC  values around 0.5 (which means 
that one out of two contacts at the interface is conserved in the two considered 
models), and several outliers are indeed observed that contemporarily show either low 
ij
pairC  and low L_rmsd values or high 
ij
pairC  and high L_rmsd values. As an 
example, the 3D representation of the models M03 and M07 submitted by the P86 
predictor for T26, responsible for the point outlined by the arrows, is shown in the 
same Figure. The L_rmsd for their superimposition is as high as 19.6 Å, 
notwithstanding a pair-wise conservation score 
ij
pairC  of 0.47 is calculated. This is 
due to a significant conformational change undergone by both the receptor and the 
ligand in the two models (RMSD for the best superposition of the two receptors and 
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the two ligands is 4.8 Å and 2.8 Å, respectively), which causes a remarkably different 
orientation of the ligand. Nevertheless, regions involved in the interaction are 
substantially the same, because the ligand somehow “follows” the receptor in its 
conformational change. This case and many others demonstrate once more that the 
RMSD cannot be selected as the only descriptors for the similarity of two docking 
solutions and that descriptors directly describing the property of interest, in this case 





pairC versus L_rmsd 
Chart of the 
ij
pairC  values versus L_rmsd values for targets T25, T26, T29 and T32. A 
comparison of the M03 and M07 models submitted by the P86 predictor for T26 and 
corresponding to the point indicated by the arrows is also shown with the ligand 
coloured in cyan and blue, respectively; residues involved in the contacts common to 
the two models are shown as red sticks. 
 
 
Conservation and Consensus maps for the multiple solutions submitted by each 
predictor 
Conservation scores have also been calculated for each set of ten models submitted 
for each CAPRI target by the same predictor. C30, C50 and C70 (data not showed). 
They correspond to amount of inter-residue contacts which are conserved in 30%, 
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50% and 70% of the models, respectively. The average avpairC  and the quality score, 
Q-score, for each predictor, obtained on the basis of the CAPRI assessment, are also 
reported.  
As expected, the inter-residue conservation rate within each set of multiple solutions 
submitted by each predictor is very variable. As an illustrative example, in Figure 
13a-b, the graphical CONS-COCOMAPS outputs (consensus maps) are shown for the 
set of ten predictions submitted by predictors P04 and P49 for target T32. For 
comparison, the intermolecular contact map for the native structure (PDB code 
3BX1120) is also reported (Figure 13c). The calculated avpairC  values are 0.003 and 
0.400 for predictors P04 and P49, respectively. Visual inspection of Figure 13a-b 
immediately indicates that the solutions proposed by predictor P49 are very 
conservative as concerns the predicted inter-residue contacts, whereas the predicted 
inter-residue contacts in the solutions proposed by predictor P04 are extremely 
diverse and spread out all over the map. Further, the maps of Figure 13b-c also 
immediately show that the consensus contact map of predictor P49 is extremely 
similar to the contact map of the native complex structure. In fact, predictor P49 
performed very well in this test case, having one acceptable, two medium quality and 






Figure 13. Consensus maps 
a-b) CONS-COCOMAPS consensus maps obtained from the 10 models submitted for 
the CAPRI target T32 by the P04 and P49 predictors. c-j) Comparison between the 
CONS-COCOMAPS consensus maps (d,f,h,j) obtained from all the 300, 310, 350 
and 350 models submitted to CAPRI for the targets T25, T26, T29 and T32, 
respectively, and the intermolecular contact maps (c,e,g,i) of the corresponding native 
structures (PDB codes: 2J59, 2HQS, 2VDU and 3BX1).  
 
We noted that there is indeed a nice correlation, especially for targets T26 and T32, 
between the success of the predictor and a high conservation of the inter-residue 
contacts. However, it is worth to remark that the opposite does not hold true, i.e. we 
also observed cases where a predictor submitted very similar predictions in terms of 
inter-residue contacts but they were far away from the native structure. For instance, 
the ten predictions submitted by predictor P89 for target T25 share an average avpairC  
as high as 0.772, notwithstanding all the predictions have been assessed as incorrect. 
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The corresponding consensus map is shown and compared with the native structure 
contact map in the Figure 14. 
 
 
Figure 14. Consensus map from the P89 predictor for T25. 
Comparison between the CONS-COCOMAPS consensus map (b) obtained from the 
10 models submitted for the CAPRI target T25 by the P89 predictor, and the 
intermolecular contact map (a) of the corresponding native structure (PDB code: 
2J59). 
 
Consensus maps for the multiple solutions submitted by all the predictors 
Overall conservation scores of the inter-residue contacts in all the models submitted 
for the analysed targets are quite low. Conservation scores at 5, 10, 15 and 20 % are 
reported in Table 2, both for all the docking models and for only the incorrect 
solutions. They correspond to the number of inter-residue contacts which are 
conserved in 5, 10, 15 and 20 models out of 100, divided by the average number of 
contacts per model. From Table 2 it is apparent that the conservation of inter-residue 
contacts in T24, T28, T29 and T36 is particularly low. The conservation score of 
contacts common to the 5% of all the models, including the correct ones, is indeed 
below 0.7 (0.398, 0.056, 0.176 and 0.643, respectively). At higher percentages the 
conservation scores for these targets are zero, with the only exception of T36, whose 
C10 value is 0.016. 
On the contrary, C5 assumes higher and similar values for the other three targets, 
from 2.274 for target T32 to 2.455 for target T25. These values are remarkably lower 
when the correct predictions are excluded from the analysis. C10 values are also quite 
similar and range from the 0.420 for target T32 to 0.576 for target T26. C15 values 
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are more variable, ranging from 0.078 for target T25 to 0.183 for target T26. 
Exclusion of the correct predictions causes a dramatic decrease of the C15 values, 
which approach to zero. At percentages of 20% or more, the conservation score is not 
higher than 0.027 for any of the analysed targets. 
 
Target Nt C5 C10 C15 C20 
T24 15818 0.398 0.000 0.000 0.000 
T24-incorrect 15618 0.322 0.000 0.000 0.000 
T25 15399 2.455 0.448 0.078 0.000 
T25-incorrect 13613 1.477 0.020 0.000 0.000 
T26 22063 2.318 0.576 0.183 0.020 
T26-incorrect 19825 2.019 0.125 0.014 0.000 
T28 29360 0.056 0.000 0.000 0.000 
T29 23890 0.176 0.000 0.000 0.000 
T29-incorrect 22923 0.000 0.000 0.000 0.000 
T32 25859 2.274 0.420 0.081 0.027 
T32-incorrect 23420 1.754 0.202 0.027 0.000 
T36 12750 0.643 0.016 0.000 0.000 
T36-incorrect 12673 0.628 0.016 0.000 0.000 
a Calculations performed upon excluding all the correct predictions. 
 
Table 2. 
Inter-residue conservation scores at different percentages for all the models submitted 






Comparison between the CONS-COCOMAPS consensus maps (b,d,f) obtained from 
all the 300, 320 and 200 models submitted to CAPRI for the targets T24, T28 and 
T36, respectively, and the intermolecular contact maps (a,c,e) of the corresponding 
native structures (PDBcodes: 2J59, 2ONI and 2W5F).  
 
Conservation rates at the residue level have been plotted in consensus maps and are 
reported in Figure 13 for T25, T26, T29 and T32 and in the Figure 15 for T24, T28 
and T36, together with the intermolecular contact map of the corresponding native 
structures (PDB codes: 2J59 121, 2HQS 122, 2ONI, 2VDU 123, 3BX1 120 and 2W5F 124 
for T24/T25, T26, T28, T29, T32 and T36, respectively). The consensus maps 
reported in Figure 13d-f-h-j and Figure 14b-d-f therefore represent the consensus 
emerging from the analysis of 200 to 350 different solutions, for each target, 
submitted by different predictors and obtained and selected on the basis of different 
methods and criteria. 
As a consequence of their very low conservation scores, the consensus maps of T24, 
T28, T29 and T36 are quite spread out and only for T24 a week signal emerges from 
the background noise (Figure 13h and Figure 14b-d-f). On the contrary, in case of 
targets T25, T26 and T32, some darker hot spots, due to the best conserved inter-






 CRkl Receptor Ligand Distance (Å) 
T25       
 0,173 TYR 35 TYR 999 3,48 
 0,167 PHE 51 ASP 996 5,82 
 0,163 PHE 51 ILE 1053 4,00 
 0,150 ASN 52 ASP 996 3,84 
 0,147 THR 44 TYR 999 2,60 
 0,140 ASN 52 TYR 999 4,20 
 0,140 ILE 46 ILE 997 3,65 
 0,137 THR 45 TYR 999 3,49 
 0,133 ILE 49 GLN 1035 6,09 
 0,130 ILE 49 ILE 995 5,29 
T26       
 0,232 GLU 293 GLU 116 3,62 
 0,210 GLU 293 THR 114 2,66 
 0,197 PHE 424 PRO 115 3,43 
 0,190 ALA 249 GLU 116 2,92 
 0,187 SER 205 GLU 116 2,66 
 0,174 PHE 424 GLU 116 5,55 
 0,174 HIS 246 GLU 116 2,79 
 0,168 MET 204 GLU 116 3,75 
 0,158 GLN 336 THR 114 2,94 
 0,158 GLY 248 GLU 116 3,94 
T29       
 0,069 TRP 236 PHE 165 7,67 
 0,063 HIS 221 PHE 165 3,65 
 0,063 VAL 195 ARG 195 6,53 
 0,060 TRP 236 GLU 204 3,03 
 0,057 PHE 231 PRO 236 3,88 
 0,057 LYS 223 THR 200 5,73 
 0,054 VAL 195 PHE 165 7,28 
 0,051 PHE 231 LEU 237 3,35 
 0,051 TRP 236 TYR 207 3,67 
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 0,051 VAL 233 THR 200 6,82 
T32       
 0,223 LEU 126 TYR 87 3,71 
 0,200 GLY 127 TYR 87 3,74 
 0,183 SER 125 TYR 87 7,68 
 0,169 GLY 100 TYR 87 4,03 
 0,160 ASN 62 TYR 87 9,91 
 0,157 SER 128 TYR 87 3,49 
 0,146 ASN 62 THR 89 4,65 
 0,143 ASN 155 THR 89 4,56 
 0,140 LEU 96 TYR 87 3,52 
 0,137 GLY 127 LEU 91 3,51 
 
Table 3. Ten most conserved inter-residue contacts. 
The ten most conserved inter-residue contacts are reported for targets T25, T26, T29 
and T32, together with corresponding distances in the native structures 120-123. 
Distances above 5 Å are outlined in bold. 
 
Interestingly, analysis of the CONS-COCOMAPS outputs indicates that among the 
ten inter-residue contacts with highest conservation rates, reported in Table 3, several 
correspond to native inter-residue contacts. Indeed, for targets T25, T26 and T32, 
seven, nine and eight of the ten most conserved contacts correspond to distances 
within 5 Å in the native structure 120-123 (see again Table 3). Considering that only 
~10% of the CAPRI models for the three targets was assessed to be correct (Table 1), 
this indicates that focusing on the consensus of predicted inter-residue contacts, rather 
than on the correctness of the entire models, can significantly increase the success rate 
of the prediction. Importantly, hot spots of the interactions are highlighted by this 
approach, such as for instance residue Tyr87 of the T32 ligand (the barley a-
amylase/subtilisin inhibitor), whose mutation to alanine has been experimentally 
shown to dramatically decrease the ligand-receptor affinity 120. A useful consensus, 
five correct contacts among the ten most conserved contacts, also emerges for T29, 
for which only 5% of the models was assessed to be correct (Table 3). Further, when 
drawing the consensus maps for targets T25, T26 and T32 using only the incorrect 
solutions, some inter-residue contacts corresponding to the native ones still emerge, 
and are clearly distinguishable from the noise (Figure 16). In particular, considering 
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only the incorrect models submitted for T25, T26 and T32, two, seven and four 
contacts, respectively, correspond to native ones (data not shown). Surprisingly, even 
T24, having no medium/high quality prediction, presents three native contacts among 
the ten most conserved ones (Table 4). Quite strikingly, these findings indicate that 
the consensus of many solutions, even incorrect according to the CAPRI definition, 
may point to the correct inter-residue contacts. If confirmed, this result could be of 
great interest and utility in applications such as mutagenesis experiments design, 
considering that the main aim of bioinformaticians and wet biologists, when 
performing macromolecular docking simulations, is often to predict the residues at the 




Comparison between the CONS-COCOMAPS consensus maps (b,d,f) obtained from 
the 268, 276 and 316 incorrect models submitted to CAPRI for the targets T25, T26 
and T32, respectively, and the intermolecular contact maps (a,c,e) of the 







 CRkl Receptor Ligand Distance (Å) 
T24       
 0,093 PHE 51 ASP 996 5,82 
 0,083 PHE 51 ILE 997 8,11 
 0,080 PHE 51 LEU 994 6,47 
 0,073 PHE 51 ILE 995 9,16 
 0,073 ILE 49 TYR 999 9,50 
 0,070 ILE 49 ILE 997 8,59 
 0,067 GLY 50 ASP 996 6,17 
 0,060 ASN 52 ASP 996 3,84 
 0,057 ASN 52 TYR 999 4,2 
 0,057 ILE 49 ASP 996 4,92 
 
Table 4 
Ten most conserved inter-residue contacts for the target T24 and corresponding 
distances in the native structure 120-123.  
 
3.5 - Conclusions  
Here I described the second computational method I developed during my PhD work 
to easily measure and visualize the consensus in multiple docking solutions. Our 
novel tool CONS-COCOMAPS uses the conservation of inter-residue contacts as an 
estimate of the similarity between different docking solutions. The conservation of 
ligand-receptor contacts is indeed used as one of the fundamental criteria in CAPRI 
for assessing the similarity of a predicted complex to the native structure, and recently 
it has been emphasized that it can be the most useful descriptor when looking at the 
biological significance of the prediction, i.e. the individuation of the interface area 102. 
To visualize the conservation, CONS-COCOMAPS uses intermolecular contact maps, 
that we recently showed to be a very effective way to visualize a biomolecular 
complex interface 4. There is virtually no limit on the number of models that can be 
compared by CONS-COCOMAPS. This novel tool is freely available to the scientific 
community (at the URL 92) and can straightforwardly be applied to the analysis of the 
outputs of one or more docking programs. 
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The application of CONS-COCOMAPS to some test-cases taken from recent CAPRI 
rounds shows that it is efficient in highlighting even a very weak consensus. 
Interestingly, in three out of the seven analysed cases, T25, T26 and T32, consensus 
maps clearly point to the native contacts (Figure 13 and Table 3). In other two cases, 
T24 and T29, although the consensus is less visually apparent from the maps (Figure 
13 and Figure 15), three and five native contacts, respectively, are included among the 
ten most conserved inter-residue contacts (Table 3 and Table 4). Importantly, in none 
of the analysed cases a false-positive consensus emerged. This opens the road to 
further studies to test and prove whether the consensus of a large number of docking 




CHAPTER 4 - CONS-RANK: a novel tool to rank multiple 





4.1 - Introduction  
Although most proteins fulfil their functions through interaction with other proteins, a 
dramatic disproportion still exists between the number of experimental structures 
solved for protein complexes and the number of structures available for single 
proteins.125 In this scenario, molecular docking, i.e. the prediction of a protein 
complex structure starting from the two separate components, is the method of choice 
for investigating the molecular basis of the recognition in many functional biological 
systems (see Chapter 1 and Appendix 2 for details about the docking technique). In a 
docking process, a large number of possible conformations (docking decoys) are 
sampled, from which native-like solutions, i.e. solutions close to the native structure, 
should be extracted. Unfortunately, correctly scoring the obtained solutions to rank 
native-like conformations before the incorrect ones is still an open problem, which is 
also object of assessment in CAPRI (Critical Assessment of PRedicted Interactions), a 
community-wide blind docking experiment.59 In the last CAPRI edition it was shown 
that, although signs of progress are evidenced, correctly ranking models to single out 
the best ones from a decoys ensemble remains a challenge.126 
During my PhD work, my group and I developed CONS-RANK (CONSensus-
RANKing), a novel method to rank multiple docking solutions. CONS-RANK deeply 
differs from other valuable algorithms developed to the aim,95,127-141 as it uses neither 
knowledge-based nor physics-based energy functions. Instead, it relies on the 
conservation of inter-residue contacts in the analysed decoys ensemble.  
The importance of inter-residue contacts when analysing docking decoys is well 
established. In the CAPRI experiment, for instance, the correctness of a prediction, 
i.e. its similarity to the native structure, is assessed based on a combination of RMSD 
criteria and of conservation of inter-residue contacts, as compared to the native 
structure.50 Interestingly, the fraction of common inter-residue contacts among a set of 
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docking decoys has been recently shown by Bonvin and colleagues142 to successfully 
apply to their clustering, and a similar concept, i.e. the atom contact frequency in a set 
of predictions, has also been recently added to the ZRANK docking pipeline.143 
Here we introduce the use of the conservation of inter-residue contacts to the task of 
ranking multiple docking solutions. The basic idea behind our approach is to move 
away from ranking methods based on the analysis of the single model per se. Rather, 
we first decompose the whole ensemble of decoys into an inter-residue contacts 
matrix (that can be visualized as a contact map, see below). Contacts that occur more 
frequently can be seen as “hot spots” for the interaction, and the decoys in the 
ensemble are ranked according to their ability to match the more frequently observed 
contacts. We had this idea when analysing several CAPRI targets to extract the most 
conserved inter-residue contacts for visualization in a “consensus map” (i.e. an 
intermolecular contact map where absence of conservation corresponds to white and 
contacts at increasing conservation appear in darker grey).5 Quite strikingly, we 
observed that even if a small fraction of native-like solutions was present in the 
decoys ensemble, a clear native-like consensus in terms of inter-residue contacts 
emerged from the background noise and, more importantly, a significant fraction of 
native contacts was included within the ten contacts with highest conservation rate. 
This finding clearly indicates that also incorrect solutions may point to some correct 
inter-residue contacts and is in line with results of the analysis that Lensink and 
Wodak performed on 20 CAPRI targets to the aim of evaluating the ability of docking 
calculations in predicting the interface in protein-protein complexes.144 Lensink and 
Wodak interestingly showed that about one quarter of the interfaces in incorrect 
docking models are in fact correctly predicted and that 70% of all the submissions 
with correct interface predictions are contributed by incorrect models. On the other 
hand, analogously to regular or irregular arrays of atoms when scattering X-ray 
beams, correct contacts, which can also be present in incorrect solutions, add 
constructively towards the native consensus, whereas incorrect contacts are expected 
to be wrong in a different way (unless the underlying docking algorithm is biased 
towards a specific wrong interface) and thus to give destructive interference, 
cancelling one another and not contributing to a false consensus. 
With these considerations on mind, we developed a simple and fast algorithm to rank 
docking decoys according to their ability to match the most conserved inter-residue 
contacts in the analysed decoys ensemble. In the following, we illustrate the algorithm 
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and demonstrate its performance on over 100 targets from three benchmarks: 
RosettaDock,64 DOCKGROUND145 and CAPRI.146,147  
 
 
4.2 - Methods 
The algorithm we have implemented is split into two sections. In the first, we analyse 
the decoys ensemble to find the most conserved inter-residue contacts. In the second, 
we rank the decoys in the ensemble according to their ability to match the most 
conserved contacts.   
Given an ensemble of N models of the same biomolecular complex, to find the most 
conserved contacts, we define the conservation rate, CRkl, of each inter-residue 




where nckl is the total number of models where residues k and l are in contact.  
To rank the models in the ensemble according to their ability to match the most 
conserved inter-residue contacts according to their conservation rate, we first 




where Mi is the total number of contacts in model i. Then, we calculate a normalized 




Note that the normalized score  of Eq. 3 coincides with the average conservation of 
the inter-residue contacts in each model. Models are ranked according to their  
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value. Within this work, two residues are defined in contact if any pair of atoms 
belonging to the two residues is closer than a cut-off distance of 5 Å. Conservation 
rates were plotted in the form of consensus contact maps as in the CONS-
COCOMAPS program.5 Contact maps for the corresponding native structures were 
obtained by COCOMAPS.4 
All the programs under CONS-RANK have been written in python, taking advantage 
of python libraries such as SciPy and Matplotlib. The program is freely available 
upon request from the authors. ROC curves were obtained by plotting the fraction of 
true positives (FTP) against the fraction of false positives (FFP).  
 
RosettaDock benchmark 
A total of 6270 decoys for the 35 targets of the Global-Unbound RosettaDock 
benchmark having at least one native-like solution64 (available at 
http://graylab.jhu.edu/docking/decoys/) have been downloaded and analysed. Models 
having a ligand RMSD (Lrmsd) <= 5 Å were classified as high/medium quality (HM). 
All models having a ligand RMSD (Lrmsd) <= 10 Å, i.e. high/medium quality plus 
acceptable ones, were classified as native-like (NL). On average, each target 




A total of 6605 decoys for the 61 targets of the DOCKGROUND benchmark145 
(available at http://dockground.bioinformatics.ku.edu/) have been downloaded and 
analysed. For the decoys classification into high/medium quality and native-like, see 
the above section. Each target presented on average 108 decoys, including about 8 
high/medium quality models and 10 native-like models.  
 
CAPRI models 
The docking models for recent CAPRI targets146,147 were downloaded from the 
official web site (available at: ftp://ftp.ebi.ac.uk/pub/databases/msd/capri/). We 
analysed all the 6 recent protein-protein targets having at least one acceptable quality 
prediction (T24, T25, T26, T29, T32 and T36, round 9 on), for which the docking 
models were made available to the public. A total of 1810 CAPRI models have been 
analysed, 300 for target 24, round 9, 300 for target 25, round 9, 310 for target 26, 
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round 10, 350 for target 29, round 13, 350 for target 32, round 15, and 200 for target 
36, round 15. Models were classified as incorrect, acceptable, medium quality or high 
quality, according to the CAPRI assessment.50,59 
 
 
4.3 - Results and Discussion  
We tested CONS-RANK on three different benchmarks: RosettaDock (global-
unbound), DOCKGROUND and CAPRI. We remind that decoys in the RosettaDock 
benchmark were obtained by Rosetta global docking searches,64 those in 
DOCKGROUND were generated by the GRAMM-X docking procedure,145 whereas 
the CAPRI decoys were submitted by different predictors using different programs 
and procedures. A total of 14685 models, corresponding to 102 targets, were 
downloaded (6270 from RosettaDock, 6605 from DOCKGROUND and 1810 from 
CAPRI) and analysed.  
Given an ensemble of multiple docking solutions for a specific target, CONS-RANK 
first calculates the conservation rate, CRkl, of each observed inter-residue contact in 
the ensemble (see Methods). Then, it calculates the average inter-residue contact 
conservation rate, or normalized score,  for each model. Models are ranked 
according to their  values: the higher the , the better the rank. A consensus map5 is 
also obtained for the ensemble of decoys provided in each benchmark for a given 
target, to possibly compare with the intermolecular contact map of the corresponding 
native structure. 
After ranking the models, the number of high/medium quality and native-like 
(acceptable or better) solutions ranked within the top five, ten and twenty positions 
was counted. To further investigate the performance of the method, we also calculated 
the Receiver Operating Characteristics (ROCs) curve for each target by plotting the 
fraction of true positives vs. the fraction of false positives. The Area Under the ROC 
Curve (AUC), compared to the 0.5 value for a random function, was used to assess 




Ranking of decoys in the Global-Unbound RosettaDock benchmark  
A total of 6270 models from the RosettaDock global-unbound benchmark were 
analysed, corresponding to 35 targets, which included 20 enzyme-inhibitor, 10 
antibody-antigen and 5 other complexes. Results of the ranking of RosettaDock 
decoys are summarized in Table 5. 
CONS-RANK proved to be effective in correctly ranking the docking solutions in the 
benchmark. It was indeed able to rank 16.8% of all the native-like solutions among 
the top ten positions, and 31.6% of them among the top twenty positions (Table 5), 
which is a striking difference from the random fraction of native-like solutions in the 
top ten positions, 1.6%. Furthermore, CONS-RANK proved to be able to specifically 
single out the high/medium quality solutions. In fact, as it is apparent from Table 5 
(columns 5-10), the percentage of high/medium quality solutions ranked among the 
top five, ten and twenty positions is consistently larger for high/medium quality 
solutions than for the total native-like ones (13.5 vs. 8.2 %, 26.5 vs. 16.8 % and 46.2 
vs. 31.6 %, in the top five, ten and twenty positions, respectively). Remarkably, 
almost half of the high/medium quality solutions are ranked within the top twenty 
positions. 
For 17 out of the 35 analysed targets (shadowed in the table), the performance of our 
ranking method is excellent (AUC values above 0.9). Except for the 1PPE target, 
having almost all correct solutions (150 out of the total 179 ones), these targets, 
including examples of enzyme-inhibitor, antibody-antigen and other complexes, 
presented a total of native-like solutions ranging from 9 to 78, corresponding to 5.3% 
and 41% of the total solutions, respectively. In two cases, targets 1ATN and 1UGH, 
all the native-like solutions were correctly ranked before any incorrect solution, 
dealing to an AUC value of 1. In these two cases the correct solutions were 13 and 65, 
corresponding to 7.0 and 36 % of the total decoys, respectively. 
Two factors may concur in explaining such a good performance of our ranking 
method when applied to the above targets: i) the incorrect solutions are instead near-
native, at least in terms of inter-molecular contacts (i.e. even the incorrect solutions 
point to some native contacts); ii) the provided solutions are really unbiased, i.e. all 
the wrong solutions are wrong in a different way, thus not pointing to a false 
consensus and making the native consensus to easily emerge. 
We have examples where either one or the other of the two factors clearly prevails. 
As it can be seen from Figure 17, the consensus map obtained using only the 162 
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incorrect solutions for the 1ATN target is completely spread, not highlighting any 
consensus. Therefore, the few (13) native-like solutions are sufficient to highlight a 
consensus towards the native contacts. On the contrary, in the case of the 2SIC target 
(AUC value 0.965), a consensus roughly corresponding to the native contacts is also 
observed in the consensus map drawn by using the 162 incorrect solutions, which 
means that a significant fraction of native contacts are also found in the solutions 
classified as incorrect (Figure 17f). 
 
Figure 17. Consensus maps for the RosettaDock 1ATN and 2SIC targets 
Comparison between the COCOMAPS4 intermolecular contact maps of the 1ATN 
and 2SIC native structures (a,d), the consensus maps obtained from all the 185 and 
179 models in the RosettaDock Global-Unbound benchmark (b,e) and the consensus 
maps obtained by only the 172 and 162, respectively, incorrect models (c,f). 
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The average AUC value over the 35 RosettaDock targets is 0.758, with 22 of them 
having an AUC value higher than 0.8. The average AUC value is significantly 
improved (to 0.799), when excluding from the analysis the 1AVZ and 1DQJ targets, 
having only two native-like solutions. For these targets our method ranked the two 
correct solutions at positions 76th - 107th and 88th - 169th, respectively, resulting in the 
particularly low AUC values of 0.174 and 0.015. A bad AUC value (0.114) was also 
obtained for target 1FBI, having only 3 native-like solutions. 
The method performed badly in only four additional cases. In particular, AUC values 
worse that random (i.e. below 0.5) were obtained for the 1ACB and 2PTC targets, 
whereas AUC values around 0.5 were obtained for the 1CSE and 1MLC targets. Of 
these, 1ACB and 1MLC/2PTC present 5 and 7 native-like solutions, corresponding to 
2.8 and 3.7/3.6 % of the total solutions. In Figure 18, a comparison between the 
consensus map for the 2PTC target (7 native-like solutions, AUC value of 0.202) and 
the native contact map is reported, from which it is apparent that the available 
solutions are biased because they point to a consensus that does not correspond to the 
native contacts. In particular, wrong regions of the ligand are docked to the receptor 
binding site. See for instance the four dark spots at the crossover of residues 30 to 45 
of the ligand, with the receptor residues around the positions 60, 150, 190 and 220, 
which are absent in the native structure contact map. However, we note that for other 
targets having a comparable or even lower fraction of native-like solutions, for 
instance 1QFU, 1FSS or 1WQ1, significantly better results are obtained. For instance 





Figure 18. Consensus map for the RosettaDock 2PTC target.  
Comparison between the COCOMAPS4 intermolecular contact map of the 2PTC 
native structure (a) and the consensus map obtained from all the 192 models in the 
RosettaDock Global-Unbound benchmark (b). 
 
Finally, the 1CSE target deserves a special mention. As said above, it presents the 
disappointingly low AUC value of 0.492, although having 19 native-like solutions 
(10% of the total). However, beside the 19 native-like models, with a Lrmsd < 10 Å, 
there are other 28 models with a Lrmsd < 12 Å. As a matter of fact, many of the 
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solutions classified as incorrect are instead “near native”, both in terms of Lrmsd and 
of inter-molecular contacts. Therefore, it is not surprising that CONS-RANK ranks 
several of these “near native” solutions in the top positions, thus decreasing the AUC 
value. To clarify the concept, in Figure 19, the center of mass of all the ligand heavy 
atoms in contact with the receptor is shown both for the native structure148 (gold) and 
for the native-like (hot pink) and non native-like (light pink) docking solutions. From 
the figure it clearly appears that, apart from two dozens of outliers, the ligand 
interface of most of the 171 ‘incorrect’ solutions is indeed correctly centered on the 
receptor binding site.  
 
 
Figure 19. 3D representation of the native structure and docking decoys for the 
RosettaDock 1CSE target.  
Receptor of the 1CSE target is shown in a light blue ribbon and surface 
representation. The center of mass of the ligand heavy atoms in contact with the 
receptor is shown as a gold sphere for the native structure (a,b), as a hot-pink sphere 
for the 19 native-like solutions (a,b) and a light-pink sphere for the 171 non native-
like solutions (b). The figure was prepared with Pymol (www.pymol.org). 
 
 
Ranking of decoys in the DOCKGROUND benchmark  
A total of 6605 decoys from the DOCKGROUND benchmark were analysed, 
corresponding to a total of 61 targets. Results of the ranking of DOCKGROUND 
decoys are summarized in Table 6  
The overall performance of the method is quite good, since it is able to rank 9.2% of 
all the native-like solutions within the top five positions, and 17.8% and 32.9% of 
them, respectively, within the top ten and twenty positions (Table 6). As in this 
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benchmark the 505 high/medium quality solutions represent almost the totality of all 
the 589 native-like ones, comparable results were obtained when considering only the 
high/medium quality solutions (Table 6 , columns 5-10) 
The method performs in an excellent way, AUC values above 0.9, on 11 targets 
(shadowed in the table), and very well for additional 10 targets, AUC values between 
0.8 and 0.9. Except the 1T6G target, having more than half native-like solutions (57 
out of the total 110 ones), these targets, presented a number of native-like solutions 
ranging from 10 to 18, corresponding to 9% to 16% of all the solutions.  
Also for this benchmark, in three cases, targets 1FM9, 1GPW and 1UGH, all the 
native-like solutions were correctly ranked before any incorrect solution, dealing to an 
AUC value of 1. In these three cases the native-like solutions were 13, 18 and 12, 
corresponding to 12, 16 and 11% of the total decoys, respectively. Analogously to 
results obtained on the RosettaDock benchmark, in some of the above cases, like for 
target 1GPW, the native consensus disappears from the consensus map when native-
like solutions are excluded from the analysis, whereas in other cases, like target 1PPF, 
spots corresponding to native contacts are also observed in the consensus map 




Figure 20. Consensus maps for the DOCKGROUND 1GPW,1PPF, 1TX6 and 
1F6M targets.  
Comparison between the intermolecular contact maps of the 1GPW, 1PPF, 1TX6 and 
1F6M native structures (a,d,g,i) and the consensus maps obtained from all the 110 
models in the DOCKGROUND benchmark (b,e,h,j). Consensus maps obtained by 
only the 92 and 100, respectively, incorrect models are also shown for 1GPW and 
1PPF (c,f). 
 
The average AUC value over the 61 targets is 0.654 and rises to 0.743 when 
excluding from the analysis the nine targets having only one or two native-like 
solutions. Analogously to results on the RosettaDock benchmark, the method 
performs badly on targets having only 1-2 native-like solutions (maximum AUC 
value 0.295). AUC values around 0.5 (ranging from 0.390 to 0.552) were also 
obtained for the 1OOK, 1P7Q and 1S6V targets, having only 4 native-like solutions 
(3.8% of the total solutions). Bad AUC values were obtained in four additional cases, 
in particular for the 1EZU, 1F6M, 1G6V and 1TX6 targets, having 8/10 native-like 
solutions out of 108/110. In all these cases, the decoys in the benchmark are biased 
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toward a wrong solution. This can be easily seen for the 1TX6 and 1F6M targets from 
Figure 20, where corresponding consensus and native contact maps are reported.  
 
 
Ranking of CAPRI targets  
A total of 1688 models for 6 CAPRI targets were ranked by CONS-RANK. Results 
are summarized in Table 7  
Performance of CONS-RANK on the CAPRI targets is strikingly good. It ranks 
32.0% of all the native-like solutions in the top ten positions, and 59.0% of them in 
the top twenty positions (Table 7). Like for the RosettaDock benchmark, the method 
specifically singles out the high/medium quality solutions. Analysis of the data in 
Table 7 (columns 5-10) indicates that the percentage of high/medium quality solutions 
ranked among the top five, ten and twenty positions is consistently larger for 
high/medium quality solutions than for the total native-like ones (20.0 vs. 18.0 %, 
43.1 vs. 32.0 % and 72.3 vs. 59.0 %, in the top five, ten and twenty positions, 
respectively). Therefore, about three quarters of all the high/medium quality solutions 
are ranked within the top twenty positions. 
The average AUC value is 0.870, and only for target T36, having one native-like 
solution out of 199 (0.5%), the performance of the method is not better than random 
(AUC value of 0.490). Instead AUC values approximate to 1 for the T25, T26, T29 
and T32 targets, having a number of native-like solutions ranging from 17 to 34 (from 
5% to 12% of the total solutions). For targets T25, T26 and T32, it is pretty clear that 
also incorrect solutions point to native contacts, as can be easily seen from the 
corresponding consensus maps (see Figure 21). In the case of target T29, the map is 
pretty spread and it is not easy to visually distinguish the native contacts from the 
background noise. However, we have previously shown that five out of the ten best 
conserved inter-residue contacts are native, i.e. correspond to distances within 5 Å in 
the native structure (while the remaining five are within a maximum distance of 7.7 
Å).5 
Target T24, having only four native-like solutions (1.3 % of the total) also has an 
AUC value as high as 0.818 (the four native-like solutions are ranked at positions 40, 
57, 62 and 66 out of 296). Also in this case, we have previously shown that the ten 
best conserved contacts among the available models correspond to an average 
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distance in the native structure below 7 Å. 5 Therefore, these and other contacts with 
high conservation rate can correctly drive the ranking of the docking decoys.5  
 
 
Figure 21. Consensus maps for the CAPRI T25, T26 and T32 targets. 
 Comparison between the consensus maps (b,e,h) obtained from all the 300, 310, and 
350 models submitted to CAPRI for the targets T25, T26 and T32, respectively, the 
consensus maps (c,f,i) obtained from only the incorrect models and the intermolecular 
contact maps (a,d,g) of the corresponding native structures (PDBcodes: 2J59, 2HQS 
and 3BX1).  
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Dependence of the method performance on the percentage of native-like solutions 
In Figure 22a, the obtained AUC values are reported vs. the percentage of native-like 
solutions available for each analysed target. As expected, AUC values are low for 
those targets having a very low percentage of native-like solutions and significantly 
increase for targets having a higher percentage of correct solutions. As a general rule, 
a percentage of 10% or better is guarantee of a performance better than random. 
However, AUC values approaching to 1 have also been found for many targets, 
especially in the RosettaDock and CAPRI benchmarks, having a percentage of native-
like solutions as low as 5% or below. It is worth noticing that for the CAPRI targets a 
percentage of native solutions of 1.3 % or more leads to AUC values above 0.80 (and 
higher than 0.96 when considering targets with a percentage of correct solutions 
above 5%).  
We also tried to correlate the maximum score obtained for each target, i.e. the  score 
of the top ranked decoy (ranging from 0.04 to 0.66), with the percentage of native-like 
solutions available. As it can be seen from Figure 22b, however, a linear correlation 
seems to emerge only for  values above 0.35 and percentages of native-like 
solutions higher than 40%. At lower values, instead, no clear correlation emerges and 
 values of 0.2 or 0.3 may correspond to a range of native-like percentages from 1 to 
40%. Therefore, unless assuming very high values (above 0.35), the  absolute value 
alone is not sufficient to recognize decoy ensembles containing a significant faction 
of correct solutions. 
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Figure 22. AUC value and Maximum score vs. the number of native-like 
solutions (%) 
 Charts of: a) the AUC-ROC value and b) the calculated Maximum score ( ) versus 
the percentage of native-like solutions for the analyzed targets in the RosettaDock, 
DOCKGROUND and CAPRI benchmarks.  
 
 
Analysis of merged decoys from RosettaDock and DOCKGROUND  
The previous analysis clearly indicated that our method outperforms on the CAPRI 
targets as compared to the RosettaDock and DOCKGROUND ones. It is reasonable to 
think that this depends on the fact that the CAPRI decoys have been obtained by 
several docking algorithms, whereas decoys in the other two analysed benchmarks 
came from single docking programs. In case this hypothesis is correct, merging 
decoys from different programs should improve the performance of the method. 
Luckily, this hypothesis could be tested as the DOCKGROUND and RosettaDock 
benchmarks have six common targets. For two of them, 1CHO and WQ1, AUC 
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values below 0.8 were obtained when using decoys from the single benchmarks, and 
no native-like solution was ranked within the top twenty positions. Therefore, we 
collected all the available decoys for these two targets and analyzed the augmented 
number of decoys (285 for target 1CHO and 296 for the target 1WQ1). Results 
summarized in Table 8, clearly show a significant improvement over results obtained 
when the single benchmarks were analyzed (Table 5 and Table 6). In particular, the 
twenty available native-like solutions for 1WQ1 were ranked between position 21 and 
70, leading to an AUC value of 0.862 (it was 0.766 and 0.697 for RosettaDock and 
DOCKGROUND, respectively). For 1CHO the prediction power of the method 
improves even more, with 18 native-like solutions, out of the total 49, ranked in the 
top 20 positions and an AUC value as high as 0.898 (it was 0.644 and 0.688 for 
RosettaDock and DOCKGROUND, respectively). 
A comparison of the native 1CHO intermolecular map with consensus maps obtained 
from the single RosettaDock and DOCKGROUND benchmarks and from the merged 
decoys is reported in Figure 23. It is pretty clear that in the RosettaDock and 
DOCKGROUND maps false contacts emerge, whose conservation competes with that 
of native-like ones. As hypothesized, such false contacts are different for the two 
benchmarks, and their conservation is consequently weakened when the decoys are 




Figure 23. Consensus maps for the RosettaDock and DOCKGROUND 1CHO 
target.  
Comparison between the COCOMAPS4 intermolecular contact map of the 1CHO 
native structure (a), the consensus map obtained from all the 175 models in the 
RosettaDock Global-Unbound benchmark (c), the consensus map obtained from the 
110 models in the DOCKGROUND benchmark (d) and the consensus map obtained 
from the 285 merged decoys from the two benchmarks (b). 
 
 
4. Conclusions  
In this chapter I described CONS-RANK, a simple and effective method to rank 
multiple docking solutions that I developed during my PhD project. The novelty and 
strength of the method is that it is based on the conservation of contacts at the 
complex interface: decoys are ranked according to their ability to match the most 
conserved contacts. We applied CONS-RANK to 102 targets from three different 
benchmarks, finding it to perform consistently well. CONS-RANK also proved able 
to specifically single out the high/medium quality solutions from the docking decoys 
ensemble. Remarkably,  46.2% and 72.3% of the total high/medium quality 
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predictions available for the RosettaDock and CAPRI targets, respectively, were 
ranked within the top twenty positions. Due to its philosophy, CONS-RANK 
performs particularly well when applied to decoys coming from different docking 
programs and procedures, as in the case of CAPRI targets, since the noise of the 
incorrect solutions from the specific docking procedures cancels, whereas the signal 
of the correct contacts gets stronger. For instance, an AUC value of 0.818 was 
obtained for the CAPRI target T24, having only 1.3% of acceptable solutions. We 
proved this concept on the 1WQ1 and 1CHO targets, which are common to the 
RosettaDock and DOCKGROUND benchmarks. Analysis of the merged decoys from 
the two benchmarks (AUC of 0.862 and 0.989 for 1WQ1 and 1CHO) indeed offers a 
clear improvement over analysis of the single benchmarks (AUC of 0.766 and 0.697 
for 1WQ1 and of 0.644 and 0.688 for 1CHO), due to an increased signal to noise ratio 
in the analysis of the conserved contacts. 
The main drawback of CONS-RANK is probably that it depends by its nature on the 
presence of correct solutions in the decoys ensemble. However, this seems to be a 
common feature to scoring algorithms, as evidenced in the last CAPRI edition, where 
it was shown that the success rate of scoring algorithms strongly depends on the 
percentage of available models of acceptable or better quality. We remind that a 
significant enrichment of native-like solutions by scoring algorithms was observed 
only in few cases, among those having a percentage of correct solutions of 5% or 
higher.126  
Nevertheless, the approach to the ranking of docking solutions we have presented is 
very well performing and robust, thus offering a valid alternative to the ranking 
methods already available. Our approach can be particularly useful to analyse docking 
solutions collected from different docking procedures. Analysis is extremely fast, and 




Summary of the ranking of RosettaDock targets. N-decoys is the total number of 
decoys; N-HM is the number of high or medium quality models; N-NL is the number 
of native-like, i.e. acceptable or better, models; R5-HM and R5-NL are the number of 
HM and NL models ranked in the top 5 positions, respectively.; R10-HM and R10-
NL are the number of HM and NL models ranked in the top 10 positions, 
respectively.; R20-HM and R20-NL are the number of HM and NL models ranked in 






















1A0O 184 1 36 0 4 0 9 0 16 
0.93
1 
1ACB 181 1 5 0 0 0 0 0 0 
0.18
6 
1AHW 171 0 9 0 0 0 3 0 5 
0.92
3 
1ATN 185 9 13 5 5 9 10 9 13 
1.00
0 
1AVW 177 1 12 0 0 0 0 0 1 
0.85
6 
1AVZ 177 0 2 0 0 0 0 0 0 
0.17
4 
1BQL 178 18 31 4 5 9 10 17 20 
0.99
1 
1BRS 179 2 28 1 2 2 4 2 8 
0.86
4 
1BVK 99 0 76 0 5 0 10 0 20 
0.93
0 
1CGI 182 18 37 4 5 8 10 13 20 
0.97
9 
1CHO 175 5 34 0 0 0 0 0 0 
0.64
4 




1DQJ 197 0 2 0 0 0 0 0 0 
0.01
5 
1FBI 190 3 3 0 0 0 0 0 0 
0.11
4 
1FSS 179 6 7 0 0 0 0 0 0 
0.71
8 
1JHL 186 0 12 0 0 0 0 0 0 
0.60
9 
1MAH 169 9 10 0 0 2 2 4 5 
0.90
6 
1MEL 181 9 36 2 5 5 10 8 18 
0.98
4 
1MLC 187 5 7 0 0 0 0 0 0 
0.50
1 
1PPE 179 43 150 1 5 2 10 8 20 
0.94
5 
1QFU 176 2 3 0 0 0 0 2 2 
0.88
6 
1SPB 174 8 14 0 0 0 0 0 0 
0.68
6 
1STF 184 16 18 5 5 10 10 14 15 
0.93
8 
1TAB 185 25 43 5 5 10 10 20 20 
0.92
0 
1TGS 185 12 46 2 5 4 10 7 20 
0.89
5 
1UDI 163 10 18 4 5 7 10 10 16 
0.99
4 
1UGH 181 33 65 3 5 6 10 11 20 
1.00
0 
1WQ1 186 0 8 0 0 0 0 0 0 
0.76
6 
2JEL 192 31 78 4 5 6 10 13 20 0.94
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5 
2KAI 180 56 77 5 5 10 10 19 20 
0.99
6 
2PTC 192 4 7 0 0 0 0 0 0 
0.20
2 
2SIC 179 14 17 5 5 7 7 10 11 
0.96
5 
2SNI 184 5 18 0 1 1 4 1 6 
0.82
2 
2TEC 183 15 21 0 0 0 0 0 0 
0.77
6 
































15.5 13.1 30.4 2.0 2.4 3.7 4.7 6.3 8.8 0.29




a Compared to N-decoys. b Compared to N-HM. c Compared to N-NL. d Values 




Summary of the ranking of the DOCKGROUND targets. N-decoys is the total 
number of decoys; N-HM is the number of high or medium quality models; N-NL is 
the number of native-like, i.e. acceptable or better, models; R5-HM and R5-NL are 
the number of HM and NL models ranked in the top 5 positions, respectively.; R10-
HM and R10-NL are the number of HM and NL models ranked in the top 10 
positions, respectively.; R20-HM and R20-NL are the number of HM and NL models 






















1A2K 102 2 2 0 0 0 0 0 0 0.295 
1A2Y 110 10 10 0 0 0 0 0 0 0.536 
1AKJ 110 10 10 0 0 1 1 9 9 0.894 
1AVW 110 10 10 0 0 0 0 0 0 0.656 
1BTH 101 1 1 0 0 0 0 0 0 0.190 
1BUIa 110 10 10 2 2 4 4 5 5 0.854 
1BUIb 110 10 10 0 0 1 1 4 4 0.822 
1BVN 110 10 12 0 0 0 0 0 0 0.770 
1CHO 110 10 15 0 0 0 0 0 0 0.688 
1DFJ 109 9 10 0 0 0 0 1 1 0.774 
1E96 110 10 10 0 0 0 0 5 5 0.839 
1EWY 110 10 10 0 0 0 0 0 0 0.624 
1EZU 110 10 10 0 0 0 0 0 0 0.190 
1F51 110 10 10 0 0 0 0 2 2 0.735 
1F6M 110 10 10 0 0 0 0 0 0 0.360 
1FM9 110 10 13 5 5 9 10 10 13 1.000 
1G20 110 10 10 0 0 0 0 0 0 0.746 
1G6V 108 8 8 0 0 0 0 0 0 0.286 
1GPQ 110 10 10 2 2 4 4 7 7 0.911 
1GPW 110 10 18 3 5 7 10 10 18 1.000 
1HE1 110 10 13 5 5 9 9 10 12 0.979 
1HE8 101 1 1 0 0 0 0 0 0 0.000 
1HXY 102 2 2 0 0 0 0 0 0 0.145 
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1JPS 110 10 10 0 0 0 0 4 4 0.829 
1KU6 110 10 10 0 0 0 0 0 0 0.706 
1L9B 110 10 10 0 0 0 0 0 0 0.557 
1MA9 110 10 10 0 0 0 0 6 6 0.849 
1NBF 110 10 10 0 0 0 0 0 0 0.713 
1OOK 104 4 4 0 0 0 0 0 0 0.552 
1OPH 110 10 10 0 0 1 1 7 7 0.888 
1P7Q 104 4 4 0 0 0 0 0 0 0.440 
1PPF 110 10 10 5 5 9 9 10 10 0.992 
1R0R 110 10 12 0 0 0 0 0 0 0.722 
1R4M 101 1 1 0 0 0 0 0 0 0.070 
1S6V 104 4 4 0 0 0 0 0 0 0.390 
1T6G 110 10 57 1 5 1 10 1 18 0.951 
1TMQ 110 10 10 0 0 0 0 0 0 0.586 
1TX6 110 10 10 0 0 0 0 0 0 0.482 
1U7F 110 10 10 0 0 2 2 8 8 0.847 
1UEX 101 1 1 0 0 0 0 0 0 0.210 
1UGH 110 10 12 5 5 9 10 10 12 1.000 
1W1I 104 4 4 0 0 0 0 0 0 0.742 
1WEJ 110 10 10 0 0 0 0 0 0 0.729 
1WQ1 110 10 12 0 0 0 0 0 0 0.697 
1XD3 110 10 10 0 0 0 0 0 0 0.722 
1XX9 102 2 2 0 0 0 0 0 0 0.255 
1YVB 110 10 10 0 0 0 0 0 0 0.650 
1ZY8c 110 10 10 5 5 9 9 10 10 0.999 
1ZY8d 110 10 10 5 5 5 5 8 8 0.955 
2A5T 101 1 1 0 0 0 0 0 0 0.090 
2BKR 110 10 11 0 0 0 0 2 2 0.788 
2BNQ 101 1 1 0 0 0 0 0 0 0.000 
2BTF 110 10 10 5 5 9 9 10 10 0.998 
2CKH 110 10 10 0 0 0 0 0 0 0.722 
2FI4 110 10 10 0 0 1 1 3 3 0.837 
2GOO 110 10 10 0 0 0 0 1 1 0.734 
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2KAI 110 10 11 0 0 0 0 0 0 0.700 
2SNI 110 10 10 0 0 0 0 0 0 0.692 
3FAP 110 10 10 0 0 0 0 3 3 0.734 
3PRO 110 10 17 4 5 6 10 8 14 0.967 






























3.3 3.3 7.3 1.7 1.9 2.9 3.4 3.7 4.9 0.280 
0.191h 
 
a 1BUI_A:C. b 1BUI_B:C. c 1ZY8_AB:K1. d 1ZY8_AB:K2. e Compared to N-decoys. 
f Compared to N-HM. g Compared to N-NL. h Values obtained by excluding the 9 




Summary of the ranking of the CAPRI targets. N-decoys is the total number of 
decoys; N-HM is the number of high or medium quality models; N-NL is the number 
of native-like, i.e. acceptable or better, models; R5-HM and R5-NL are the number of 
HM and NL models ranked in the top 5 positions, respectively.; R10-HM and R10-
NL are the number of HM and NL models ranked in the top 10 positions, 
respectively.; R20-HM and R20-NL are the number of HM and NL models ranked in 






















T24 296 0 4 0 0 0 0 0 0 0.818 
T25 268 13 32 2 5 5 10 9 19 0.990 
T26 276 15 34 3 8 10 10 13 20 0.986 
T29 333 9 17 4 5 5 10 9 16 0.965 
T32 316 28 34 4 4 8 9 16 17 0.969 


























281.3 10.8 20.3 2.2 3.7 4.7 6.5 7.8 12.0 0.870 
ST-
DEV 
47.1 10.5 15.2 1.8 3.1 4.1 5.0 6.6 9.4 0.197 
 





Summary of the ranking of merged decoys from RosettaDock and DOCKGROUND 
for the 1CHO and 1WQ1 targets. N-decoys is the total number of decoys; N-HM is 
the number of high or medium quality models; N-NL is the number of native-like, i.e. 
acceptable or better, models; R5-HM and R5-NL are the number of HM and NL 
models ranked in the top 5 positions, respectively.; R10-HM and R10-NL are the 
number of HM and NL models ranked in the top 10 positions, respectively.; R20-HM 



































0 0 0 0 0 0 0.862 





CHAPTER 5 - Study of the interaction between celiac auto-




5.1 - Introduction 
 
The immune system 
One of the most important and fascinating example of protein-protein interaction is 
the complex made by an antigen and its antibody. 
The antibodies, or immunoglobulins, are a class of protein at the basis of the immune 
system. The immune system, in fact, provides a defense mechanism against foreign 
parasites such as virus and bacteria. Foreign invaders, the antigens, are recognized 
through specific binding of the antibodies. The site on foreign molecules that are 
specifically recognized by the antibody is called antigenic determinant or epitope.  
Structurally, an antibody is a “Y”-shaped protein composed by a light (L) and a heavy 
(H) chain linked together by disulfide bonds (see Figure 24). There are two different 
classes, or isotypes, of light chains, λ and κ, but there is no known functional 
distinction between them. Heavy chains, by contrast, have five different isotypes that 
divide the antibodies into different functional classes: IgG, IgM, IgA, IgD and IgE, 
each with different effector properties in the elimination of the antigen. Each class of 
heavy chain can combine with either of the two different classes of the light chain. 
The IgG class is the major type of immunoglobulin in normal human serum, and it 





Figure 24. Schematic representation of an antibody. 
On the left: The heavy (in green and gray) and light (in orange and gray) chains are 
represented, connetected by disulphide bonds (in black). The variable region is 
highlight in green and orange for the H and L chains, respectively. On the right: the 
detail of the CDR region, interacting with the antige, is represented.  
 
Both light and heavy chains are built up from one amino-terminal variable domain 
(VL and VH, respectively) (the two “arms” of the Y) and one carboxy-terminal 
constant domain (CL and CH1, CH2 and CH3) (see Figure 24) . The variable domains 
are not uniformly variable throughout their length; in particular, three small regions 
for both L and H chains show much more variability than the rest of it: they are called 
complementary determining regions (CDRs), made by six hypervariable loops, as 
showed in Figure 25. They are indicated with L1, L2, L3, H1, H2, H3 depending on 
the chain, and represent the binding site for the antibody, presenting a specific and 
complementary structure for the antigen recognition. 
 
 
Figure 25. Schematic representation of the six hypervariable loops 
Side (on the left) and top (on the right) view of a schematic representation of 




This six loops show a variability in the length and in the amino acids composition, 
being specific for the antigen. In particular, the loop H3 is the most variable in 
sequence and structure, having a key role in the antigen recognition.  
Therefore, the study of a binding between and an antibody and its can be focused on 
the analysis of the six hypervariable loops.149  
 
The autoimmunity and celiac disease 
The antibody-antigen recognition is an high precise and specific interaction, but 
sometimes the immune system mistakes parts of the body as a pathogen, attacking its 
own cells and proteins. When the body arise an immune response against a self 
antigen, there is the development of a peculiar class of disease, termed autoimmune 
disease. This is a quite common pathologies (involving more than the 5% of the 
population), and their gravity can vary on the basis of the organ and tissue that is 
erroneously recognize by auto-antibodies, i.e. antibodies direct against a self antigen. 
Multiple sclerosis, Mellitus diabetes, some kind of allergies are all examples of 
autoimmune disease, and are that characterized by the presence of auto-
antibodies.150,151  
 
One of the most common food intolerance in Europe has been classified as auto-
immune disease, being characterized by the presence of auto-antibodies: the celiac 
disease.150Celiac disease is a multifactorial disorder affecting approximately 1 in 100 
individual in the European population.152 It is a long-life food intolerance affecting 
susceptible individuals  and caused by the exposure to the gluten, the constituent 
protein in wheat and cereal.153 The presence of gluten causes an abnormal immune 
response not only against the gluten’s proteins, but also againt the self antigen Tissue 
Transglutaminase (or type 2 Transglutaminase TG2).154 The clinical consequence is 
an intestinal mucosal injury and malabsorption; the absence of typical symptoms 
makes the celiac disease not easy to diagnose. 155 
Therefore, the disease is characterized by the presence of specific antibodies 
recognizing gliadins (the food proteins comes from the gluten digestion) and the 
autoantigen TG2. TG2 is a member of a family of seven isoforms of enzymes 
involved in protein cross-linking. It is a Ca2+ -dependent ubiquitous intracellular 
enzyme that catalyzes the covalent and irreversible formation of gamma glutamyl-
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lysine bonds. Furthermore, TG2 plays a role in the transduction of extracellular 
signals, mediated by its additional GTP-hydrolyzing activity.156  
Human TG2 consists of four domains: 
- the N-terminal domain, with a β -sandwich structure; 
- the enzyme Core domain, formed by a series of α-helices; 
- two C-terminal domains, β1 and β2, containing β-structures arranged in 
barrel-like conformations. 
The catalytic site, the so called triad,157 formed by Cys 277, His 335 and Asp 358, as 
well as the Ca2+ and the GTP binding sites, are located in the Core domain and the 
nearby first β-barrel domain. 158 
Experimental x-ray structures of several transglutaminase have been crystallized,158-
161 proving that the four TG2’s domains can organize themselves in two different 
ways. In one case, named closed conformation, the two C-terminal domains are 
folded on the Core domain, hiding the active site; in the other one, named open 
conformation, the four domains are straight on an axis, exposing the active site (see 
Figure 26). From the superimposition of the two TG2’s conformations is so apparent 
that the conformational change is not changing the 3D orientation of the first two 
domains between the closed and open conformation. To crystallize and so to solve the 
structure of the two conformations of the TG2, it was required the stabilization of the 
two transient state. Then, the human TG2 open conformation has been crystallized in 








Figure 26. Overall structures of CDP-bound and inhibitor-bound TG2 
The crystal structures are shown as ribbons, and simplified cartoons are included for 
clarity.(A and B) The N-terminal β-sandwich is shown in blue (N), the catalytic 
domain (Core) in green, and the C-terminal β -barrels (β1 and β2) in yellow and red, 
respectively. (A) GDP-bound TG2 (PDB ID: 1KV3158). (B) TG2 inhibited with the 
active-site inhibitor Ac-P(DON)LPF-NH2 (PDB ID: 2Q3Z162).(C) The N-terminal β-
sandwich and catalytic domains of the two structures are superimposed, highlighting 
the conformational change. The GDP-bound structure (named “TG2-closed”) is 
shown in blue and the inhibitor-bound structure (named “TG2-open”) in gold. 
 
Studies conducted on celiac patients have demonstrated the presence of the auto-
antibodies against the TG2 in the blood of the patients as a peculiarity of this illness.  
The TG2/auto-antibody interaction has so a fundamental role in the study of the 
disease, founding a substantial role in the diagnosis.154,163 In the previous year, in fact, 
the only way to diagnose this illness was through an intestinal biopsy, to check an 
eventual tissue damage. Nowadays, a blood test is enough for a first diagnosis of it, 
checking the presence of auto-antibody specific for the TG2 through an ELISA 
test.154,163  
Due to the key role that TG2 seems to have in the pathogenesis of celiac disease, and 
the fundamental role in the diagnosis strategy, it is of great importance the 
characterization at atomic levels of the TG2’s epitope and, consequently, the binging 
mode of the complex TG2/auto-antibody. 
 
Experimental studies 
For this reason, in the last decades, some experimental studies have been performed. 
Sblattero et al. isolated and characterized in sequence some anti-transglutaminase 
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antibodies from blood of celiac patients,7 and then, using transglutaminase gene 
fragments, they identified a region of TG2 recognized by these antibodies (in 
particular three, called clone 2.8, clone 4.1 and clone 3.7) as being conformational 
and located in the Core domain of the enzyme; in particular, they proved the epitope 
belong to the fragment 140-376, showed in Figure 27 in red and in blue for the TG2-
closed and TG2-open, respectively.155 
 
Figure 27. Representation of the Core domain of TG2 
The closed (on the left) and open (on the right) conformation of TG2 are showed in 
cartoon. The fragment 140-376 in which the epitope is located is highlighted in red 
(for the TG2-closed) and in blue (for the TG2-open). 
 
Due to the importance of anti-TG2 antibodies in diagnosis and pathogenesis of the 
celiac disease, we believe that the characterization at atomic level of the interaction 
between the TG2 (both closed and open conformation) with clone 2.8, clone 3.7 and 
clone 4.1 could be of great interest. For this reason, we performed docking simulation 
between the autoantibody the two TG2’s conformations and the three Abs from CD 






5.2 - Methods 
Abs and TG2 strucutres 
The structures of both TG2’s closed and open conformation were experimental solved 
and deposited in the Protein Data Bank, with the code 1KV3 and 2Q3Z, respectively. 
The three anti-TG2 antibodies clone 2.8, clone 3.7 and clone 4.1 were isolated from 
celiac patients blood and the sequences were characterized by the group of the prof. 
Sblattero, University of Piemonte Orientale (Italy). Then, the variable domain 
structures of clone 2.8, clone 3.7 and clone 4.1 were modeled by the RosettaAntibody 
Fv homology modeling server,164 using the full refinement protocol option.  
 
Docking simulations 
The TG2s crystal structures and the obtained Abs models were then used for protein-
protein docking simulations, performed by the ClusPro 2.0 server (see Chapter 1 and 
Appendix 2 for details about docking technique).56 By default, ClusPro server docks 
the two proteins using PIPER rigid-body docking algorithm. The top 2000 complexes 
generated by PIPER are then filtered according to electrostatic and desolvation 
energies and retained for further processing. The retained 2000 conformations are 
then clustered according to interface RMSD values and the top 10 docked models, 
following a short Charmm10 energy minimization, are made available for download. 
In all the simulations, all the Abs’ residues that do not fall into the Complementary 
Determining Region (CDR) were masked (ClusPro Antibody Mode). Differently, for 
the two TG2 conformations all the residues were considered on an equal basis. 
 
Analysis 
The representative structures of the top clusters for each simulation were analyzed. To 
analyze the docking results we used script on the basis of COCOMAPS web tool. 
 
 
5.3 - Results and Discussion 
We performed docking simulations to obtain the structure of the complex between the 
TG2 and the antibodies anti-TG2 isolated from CD patients. For both closed 
(TG2closed) and open (TG2open) conformation of TG2, the experimental structures 
from Protein Data Bank were used, while the Abs structure of clone 2.8, clone 3.7 and 
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clone 4.1 were reliably predicted by homology modeling using Rosetta Antibody. The 
docking simulations were performed by ClusPro 2.0.  
 
In the first moment, we ran a set of six docking simulation, testing all the combination 
between the three Abs (clone 2.8, clone 3.7 and clone 4.1) with the two possible 
experimental conformation of the antigen TG2 (closed and open conformation). 
However, as experimental data showed that TG2 interacts with these Abs using only 
the Core domain, indicating that the epitope should be in that region, we additionally 
ran another set of docking simulations in according with the experimental data, for a 
total of twelve simulations. In fact, for the same systems, we repeated the docking 
using only the 1-376 fragment for the two TG2open and TG2closed structures. 
     
FIRST SET OF SIMULATION  SECOND SET OF SIMULATION 
TG2closed + clone 2.8  TG2closed (fragment 1-376)+ clone 2.8 
TG2closed + clone 4.1  TG2closed (fragment 1-376)+ clone 4.1 
TG2closed + clone 3.7  TG2closed (fragment 1-376)+ clone 3.7 
TG2open + clone 2.8  TG2open (fragment 1-376)+ clone 2.8 
TG2open + clone 4.1  TG2open (fragment 1-376)+ clone 4.1 
TG2open + clone 3.7  TG2open (fragment 1-376)+ clone 3.7 
 
Table 9 
List of the TG2-Ab systems used in the first (on the left) and second (on the right) set 
of simulations. 
 
In our ClusPro simulations, as generally done for antibodies, the Abs were fixed and 
all their residues not falling into the CDR were masked, while all the antigen’s 
residues were considered unmasked, and therefore available for the interaction. 
For each of the twelve simulations, we then analyzed the representative structure of 
the top three clusters, that should capture most of the important rigid-body binding 
geometries, and we compared the results.  
The docking results of the first set of simulations (using the whole TG2s’ residues) 
corresponded to the ones obtained from the second set (using only the 1-376 fragment 
of the two TG2 conformation - Figure 27), therefore the data and analysis show below 
concern the simulations using only the second set of them (see Table 9). 
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To easily and intuitively compare the solutions came from the various simulations, we 
made intermolecular contact maps for the best three clusters for each of the six 







Figure 28. Contact maps 
Contact maps for the best three clusters between the Abs (clone 2.8, clone 4.1 and 
clone 3.7) and the TG2 1-376 fragment for both the closed and the open 
conformation. Labels and titles have been added of each contact map. The population 
of each cluster is also indicated on the top of the map. 
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Abs/TG2 open systems 
In the simulations involving the open conformation of TG2, the analysis of clone 
2.8/TG2open system showed that: 
- the first and second top solutions are very populated; 
- the top three solutions present more o less the same epitope, made up of three 
interacting zones: the first zone is around the amino acids 200-210, the second 
one is around the amino acid 230, and the third one is around the amino acid 
365. We defined this epitope as “EP1”. 
Summing the population of these three clusters, we obtained more than 500/2000, 
increases our confidence in the EP1 solution as a close-native one. 
Looking at the results for clone 4.1/TG2open complex, the first best solution 
(population: 111) clearly pointed in the N-terminal domain of TG2, so we excluded 
the this solution as disagreement with the experimental data. The second best solution 
(population: 96) presented EP1 as epitope, while the third one pointed in the Core, but 
in a region different from EP1.  
Finally, in the clone 3.7/TG2 open solutions, the second one is the only one involving 
the Core domain in the interaction, but is a different region from EP1. 
 
Abs/TG2 closed systems 
In the simulations involving the closed conformation of TG2, the first top solution for 
clone 2.8/TG2closed showed again EP1 as epitope, even though the preference (in 
terms of population) is less if compared with the clone 2.8/TG2 open.  
The clone 4.1/TG2closed presented similar results, again with a preference for EP1, 
while the clone 3.7/TG2closed system seed to prefer other interaction regions.  
 
In conclusion, the analysis of the contact maps showed that the complexes involving 
clone 2.8 and clone 4.1 preferred to interact through EP1, and this solution is 
preferential in particular for the clone 2.8/TG2open system, in clear accord with the 
experimental data. Therefore, this increases our confidence in proposing EP1 as 
possible epitope for TG2. 
 
Finding the key-residues for the interaction 
To characterize the interaction interface and have a clue about the most common TG2 
residues at the interface, we performed a statistical analysis counting how many times 
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a TG2 residue is at the interface with the Ab in the best top twenty solutions for each 
simulation. In particular, a TG2 residue is at the interface if any atom is closer than 
the cut-off distance of 5 Å from any Ab’s residue. In Table 10 are reported the 
residues that are at the interface at least in the 20% of the models analyzed.  
 
The analysis of Table 10, such as the contact maps in Figure 28, shows that the TG2’s 
regions involved in the interaction are the same in both the complexes TG2/clone 2.8 
and TG2/clone 4.1, in according with the experimental data. In particular, it is 
possible to identify three specific regions: 
- region 200-230; 
- region around the residue 345; 
- region around the residue 365 
 
Therefore, the statistical analysis of the top twenty clusters for the systems involving 
clone 2.8 and clone 4.1, interacting with both open and closed conformation of TG2, 
converges towards EP1 (defined of the basis of the best solution for the system 
clone2.8/TG2-open), with the only addition of the region around the residue 345. This 




aa TG2  Clone2.8 Clone4.1 Clone3.7 
TRP 142 2.5 0.0 22.5 
TYR 149 2.5 7.5 27.5 
SER 152 7.5 15.0 27.5 
GLU 153 7.5 5.0 40.0 
GLU 154 7.5 17.5 35.0 
GLU 155 7.5 15.0 22.5 
ARG 156 2.5 2.5 35.0 
GLN 157 2.5 10.0 32.5 
GLU 158 2.5 12.5 27.5 
TYR 159 5.0 7.5 20.0 
THR 162 2.5 17.5 20.0 
GLN 166 0.0 10.0 20.0 
LYS 173 10.0 20.0 15.0 
PRO 201 20.0 12.5 5.0 
LYS 202 35.0 20.0 5.0 
LYS 205 40.0 30.0 7.5 
ASN 206 30.0 30.0 2.5 
ARG 209 35.0 35.0 5.0 
ARG 213 25.0 25.0 0.0 
TYR 219 27.5 15.0 0.0 
ARG 222 27.5 20.0 2.5 
ASN 231 27.5 20.0 7.5 
ASP 232 32.5 17.5 15.0 
ASP 233 25.0 17.5 7.5 
ARG 296 5.0 10.0 20.0 
ASN 308 20.0 2.5 17.5 
SER 309 20.0 5.0 10.0 
GLU 314 20.0 5.0 10.0 
TYR 315 20.0 10.0 7.5 
PHE 316 22.5 2.5 17.5 
SER 328 20.0 2.5 17.5 
GLU 329 22.5 12.5 17.5 
ARG 344 17.5 22.5 2.5 
PRO 345 22.5 22.5 0.0 
ASP 346 20.0 30.0 0.0 
LEU 347 22.5 25.0 0.0 
GLN 348 25.0 25.0 10.0 
PRO 349 20.0 20.0 10.0 
TRP 354 5.0 12.5 22.5 
GLU 363 35.0 15.0 20.0 
LYS 364 35.0 17.5 17.5 
SER 365 45.0 22.5 20.0 
GLU 366 52.5 25.0 15.0 
GLY 367 45.0 22.5 17.5 
THR 368 37.5 17.5 17.5 
TYR 369 22.5 15.0 7.5 
Table 10 
List of TG2’s amino acids numbering and typology at the interface with the Abs at 
least in the 20% of all the models analyzed (columns 1-2), with the corresponding 
percentage (column 3-5). 
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Simulations on the mutants 
A valid experimental approach to identify and verify the nature of a binding site is 
testing the affinity of mutants of the protein. A mutant has the same structure of the 
wild-type protein itself, with exception of the amino acids that are considered 
involved in the binding site; in fact, these residue are mutated in a different amino 
acid with different chemical-physical properties. If the mutated residues are involve in 
the interactions, their mutation will compromise the binding with the molecule 
partner. 
Then, to test the reliability of our result (EP1 as binging site), we performed docking 
simulations testing mutants of the TG2. The simulations were so performed on the 
system that showed the highest selectivity for EP1: clone2.8/TG2-open. The method 
is based on the idea that if the mutations are able to decrease a so strong affinity in 
silico, probably they can give the same result in experimental tests too. So, we should 
be able to identity the most promising mutants. 
Considering the residues in Table 10 with a high frequence at the interface, we 
designed the list of mutants reported in Table 11, in which all the key residues were 
muted in alanine, and the region 360-369 (corresponding to a loop) was deleted.  
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Mutant Mutated residues 
M1 202+205 mutati in A 
M2 209+213 mutati in A 
M3 232+366 mutati in A 
M4 202+205+232 mutati in A 
M5 202+205+209+213 mutati in A         
M6 202+205+232+366 mutati in A 
M7 202+205+209+213+222 mutati in A 
M8 360-369 deleted 
M9 202+205 mutati in A e loop 360-369 deleted 
M10 202+205+209+232 mutati in A e loop 360-369 deleted  
M11 202+205+206+209+232+346 mutati in A e loop  360-369 deleted 
M12 202+205+206+209+213+231+232+233+346+347+348 mutati in A e  
loop  
360-369 deleted M13 365+366+368 mutati in A 
M14 365+366 mutati in A    368 mutato in V 
M15 202+205+232+365+366+368 mutati in A 
M16 202+205+232+365+366 mutati in A    368 mutato in V 
M17 202+205+232+365+366+368+346 
M18 202+205+209+232+365+366+368 
M19 202+205+209+232+365+366+368 mutato in V 
M20 202+205+209+232+346+348+365+366+368 
M21 202+205+209+232+346+348+ loop(360-369) deleted 
 
Table 11 
List of the mutants of the 1-376 TG2-open’s fragment used in the docking simulations 
with clone 2.8 
 
In Figure 29 are reported the results of the docking simulations between clone 2.8 and 
the TG2’s mutants (listed in Table 11) compared with the wild-type (WT) TG2 result. 
In particular, we looked at the population of the cluster reporting EP1 as 
representative solution, due to the fact that in the docking technique the cluster’s 
population is generally a signal about how preferential is the solution. From FIGX it 
is apparent that the mutants involving only one of the three regions characterizing 
EP1, i.e. the one around 200-210 (M1 and M2 mutants) or around 360-369 (M8 
mutant), show again EP1 as preferential binding mode. In fact, in these cases EP1 is 
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the most populated cluster if compared with the other solution, showing only a little 
reduction in the affinity (the EP1’s cluster population in these cases is less than the 
EP1’s cluster population in the WT). Again, the mutants M5 and M7 have only one 
key-region of EP1 changed in alanine but a major number of residues compared with 
M1, M2 and M8. In fact, the mutations have a stronger negative effect on the binding 
affinity, as showed by the fall of EP1’s cluster position and population (becoming the 
third/fourth cluster in order of population).  
We can observe a similar effect also for the mutant M3, that is characterized by one 
mutation in two of the EP1’s key-regions (see Table 11). 
Therefore, looking at the results of the TG2 mutants’ simulations, it is apparent that 
the most strong effect on the TG2/clone 2.8 binding is performed by the mutants that 
have mutations in all the three key-regions of EP1. In fact, the mutant M6, M15, M16 
and in particular M18, M19, M20 and M21 present a disappearance of the solution 
EP1 between the top 30 models. 
 
Figure 29 
The histrogram’s bars report the cluster population corresponding to EP1 epitope (in 
green) and the population of the most populated cluster (in red) if the solution does 
not correspond to EP1. In this case, the number reported on the green bar indicates the 
rank of the cluster presenting EP1 as solution. For example, in the case of M6 mutant, 
the most populated cluster has a population of 83 (as indicated by the high of the red 
bar), while the cluster presenting EP1 as binding mode has a population of 27 (as 
indicated by the high of the green bar) and it is th 12th cluster ranked in order of 
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population. The WT is indicated as 0, and the mutants are labels with the numeration 
reported in Table 11. 
 
On the basis of the results and the effect of the mutations, the idea is that TG2 binds 
the antibody through epitope EP1, characterized by three anchor regions: the region 
200-230, the region around 345 and the one around the loop 365. Due to the topology 
of the binding site, made by three anchor sites, the mutation of only one site decrease 
the affinity between the two proteins but it is not enough to prevent the binding. Only 
the mutation of all the three site is able to compromise the binding, destroying the 
interacting network of the three anchor points (Figure 29).  
The mutants that in silico showed the most promising performance were suggested to 
prof. Daniele Sblattero, Department of Medical Science, University of Piemonte 
Orientale (Italy), for experimental tests. 
 
 
5.4 - Conclusion 
In this chapter I described the docking study I performed to obtain a molecular model 
of the complex between the celiac autoantibodies (clone 2.8, clone 4.1 and clone 4.1) 
and the auto-antigen TG2.  The present investigation provides better picture and gives 
useful insight into the orientation and characterization of the complex’s binding site, 
showing that the interaction involve the TG2 epitope made of three anchor sites, all of 
them fundamental for the binding.  
The improvement achieved in recent years by methods for predicting structures and 
protein-protein interaction give us the confidence in the results of our computational 
approach. Most importantly, the model is validated by its ability to explain the 
experimental data, its coherence resulting by different docking simulations (with 
clone 2.8, clone 4.1 and clone 3.7) and by the comparison with the simulations 
performed on 21 mutants of TG2. 
Due to the crucial involvement of the complex TG2-antoantibody in the celiac 
disease, the diagnosis application and the promising therapeutic applications, the 
proposed model could help rationalizing the experiments as crucial step for the study 
of the celiac disease mechanism, the improvement of diagnosis strategies and the 
rational design of molecules for pharmacological and therapeutic purposes.  
 
 94 
CHAPTER 6 - Prediction and analysis of an idiotype - anti-
idiotype antibody complex associated to celiac disease 
 
 
6.1 - Introduction  
 
The idiotypic network 
The antigenic determinants of antibodies is named “idiotype” and it is located in the 
variable region of the antibodies.165,166 The 1984 Nobel laureate Jerne proposed an 
idiotypic network theory,167 predicting that the idiotypic determinants of each 
antibody are recognized by those of another antibody, thus creating an “idiotypic 
network” through which immunoglobulins expression might be controlled. In fact, 
under physiological conditions, each antigenic stimulation (due to an antigen Ag) 
leads to the production of idiotype antibodies (termed Ab1) against Ag and then the 
unique structure of its antigen-binding site triggers the immune system to produce a 
series of anti-idiotypes directed against the Ab1’s antigenic-determinant, termed Ab2 
(Figure 30). Finally, anti- anti-idiotypes antibodies (Ab3) are induced by the presence 
of Ab2, which may have binding capabilities similar to those of Ab1, recognizing the 
original Ag.168,169 
This idiotypic Ab1-Ab2-Ab3 network has a crucial role in the regulation of immune 
response to external and self antigens. For example, in a healthy subject and after 
eradication of the invading organism (the Ag), anti-idiotype antibodies Ab2 are useful 
to decrease the idiotype Ab1 titers to lower levels,168 and their presence can maintain 
B cell memory during the absence of antigen in the system, helping in the 








In some cases Ab2 can also act inhibiting the binding of Ab1 to the original antigen. 
On the basis of this “inhibiting” property, the Ab2 are classified as follows (Figure 
30): 
• “Ab2-alpha” (Ab2α are directed against idiotypes which are distinct from the 
antigen-binding site on Ab1. In this case, the idiotype/anti-idiotype interaction 
does not inhibit the Ab1-Ag binding.  
• “Ab2-beta” (Ab2 β) binds exactly the antigen-binding site of the Ab1 
antibody, inhibiting the Ab1-Ag binding. In fact, this class of anti-idiotypes 
interacts with Ab1 through structures that resemble the epitope of the antigen, 
carrying a so defined “internal image” of it.  
• “Ab2-gamma” (Ab2γ) refers to antibodies directed against idiotypes close to, 
rather than within, the antigen-binding site. So, they can sterically inhibit the 
Ab1-Ag binding such as Ab2β, but they do not carry an internal image of the 




Figure 30. The idiotypic network 
An antigen Ag is recognized by its antibody Ab1. The Ab1 becomes itself an antigen 
eliciting the production of anti-antibodies Ab2. This response can be divided into: i) 
an antigen-noninhibitable group (Ab2α), ii) an antigen-inhibitable group bringing an 
internal image of the Ag (Ab2β), and iii) an antigen-inhibitable group due to steric 
hindrance with the antigen binding-site (Ab2γ).  
 
The theory of the “internal image” was then experimentally proved, showing that an 
anti-idiotypic antibody can provide an approximate topological and binding-group 
mimicry of an external antigen in different ways. Ban et al.171 determined the crystal 
structure of an anti-idiotypic antibody 409.5.3 raised against the antibody that 
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neutralizes E2 peplomer, a large glycoprotein of feline infectious peritonitis virus 
FIPV (wwPDB code: 1IAI), describing also the mimicry of the Ab2 409.5.3 for the 
original antigen E2. The experimental data, in fact, showed that Ab2, when injected 
back into mice, elicited the production of Ab3s that had FIPV neutralizing properties. 
A comparison of the sequence of the Ab2’s CDR loops with the antigen showed 
sequence homology in two regions of about six amino acids, both regions providing 
important contacts with Ab1. This evidence was also consistent with experimental 
tests, showing that Ab1 recognizes an epitope on the E2 peplomer even when the E2 
protein is completely denaturated.172 This suggests that Ab1 may be specific not 
strictly for a structurally unique epitope but for a sequence-unique epitope on the 
antigen. 
 
However, other cases of Ab2 mimicry for the Ag was proved even though there is no 
sequence homology between the anti-idiotype and the antigen. Bradford et al.173 
determined the crystal structure of an anti-hen-egg-white lysozyme antibody (D1.3) 
complexed with an anti-idiotypic antibody (E5.2) (wwPDB34 code: 1DVF) and they 
discussed the molecular mimicry of E5.2 for the original antigen HEL, showing that 
the mimicry did not depend on amino acid sequence homologies between the Ag and 
Ab2. In fact, they compared the structure of E5.2 and HEL both in complex with 
Ab1-D1.3. After superimposition of D1.3, they did not found a similar topology 
between the E5.2 and HEL, but they did find similar size of the solvated cavities, 
almost the same number of van der Waals contacts, the same patterns in the 
hydrophilic interaction, and six of the 14 interface hydrogen bonds in D1.3-E5.2 
conserved also in D1.3-HEL complex. In particular, they found that much of the 
mimicry of E5.2 for HEL resides in the similar interaction made by the CDR loop H3 
of the anti-idiotype and two particular residues of the Ag. Finally, also previous 
experimental data about CDR side-chain mutations of D1.3174 are consistent with the 
structural/functional mimicry of E5.2 for HEL. 
Even though internal image on anti-idiotypes are three-dimensional amino acid 
constructs, they can mimic also peptides epitopes. This is the case of the complex 
between an antibody and the angiotensin II peptide. The elicited Ab3 recognizes the 
original antigen with high affinity. Backbone atoms of this peptides closely resemble 
a CDR loop belongin to the canonical structure of the CDR loop L3.175 This suggest 
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that the Ab2 has a CDR-L3 that resembles angiotensis II, mimicking the peptide with 
this single hypervariable loop.176  
 
Applications of anti-idiotypic antibodies in medicine  
Due to the key role of the immune system in the defence against diseases, the 
idiotypic network can be harnessed to develop new therapeutic strategies in many 
possible ways. 
First of all, the anti-idiotype Ab2 offers an elegant concept for developing vaccines 
not based on the conventional approach of using nominal antigens. In particular, 
because of the Ab2β  anti-idiotype brings the internal image of the Ag, it can induce 
specific immune responses similar to response induced by nominal Ag and it can be 
used to surrogate Ag. In fact, immunization with Ab2β  can lead to the generation of 
anti - anti-Id antibodies Ab3 that recognize the corresponding original Ag identified 
by the Ab1. These so called anti-idiotype vaccines (anti-Id vaccines) have many 
advantages over conventional vaccines. For example, they contain neither nominal Ag 
nor its fragments. This exclude the possibility that anti-Id vaccines would have the 
same undesired effects which are sometimes associated with conventional antigen 
vaccines. There are also practical, economical and biological advantages.177 In fact, 
anti-Id vaccines do not depend on the availability of large amounts of pure Ag, which 
often is a limiting economical factor in vaccine production and, by virtue of their 
being proteins, they can be easily manipulated.178 
 
Anti-idiotypic antibody for cancer immunotherapy 
Vaccination can become a decisive factor in situation where the responding immune 
system is immature or suppressed, such as in cancer patients, who may be 
immunodeficient or tolerant against their own tumour. 
In particular, active immunotherapy is a really attractive therapeutic approach for 
tumours because it harnesses the body’s immune potential to attack malignant cells in 
an antigen-specific manner and have immunological memory, but normally cancer 
patients are immunodeficient or tolerant against their own tumour. A common 
explanation for the absence of anti-tumour immunity is that the immune system has 
been tolerized by the tumour antigen. An effective method of breaking tolerance is to 
present the critical epitope in a different molecular environment to the tolerized host. 
 98 
This is impossible to do with most tumour antigens because they are chemically  
elaborate and difficult to purify.179 In this contest anti-Id Ab2β, mimicking the three-
dimensional shapes of antigens, can present the antigen in a different molecular 
environment and it can be considered a powerful approach to generate targeted 
antigen immunity.178  
This strategy has been used for the last decades180. In particular, anti-idiotype 
antibodies have been usefully used to implement active immunotherapy in patients 
with breast cancer,181,182 colorectal carcinoma,183 melanoma and ovarian 
lymphoma.184,185 Nowadays, induction of adaptive tumour-antigen-specific immune 
responses continues to hold great promise for cancer prevention and therapy. 
Ab2 anti-idiotypes are having great application in the development of new therapeutic 
approaches in cancer treatment, but they seem promising also in a lot of other 
important applications, such us the design of future anti-HIV strategies against AIDS, 
one of the deeply challenged in the case of persistent infections,186,187 or as potent 
anticoagulant as an ideal antidote in restoring normal hemostasis.188  
 
Although the Ab2b class of anti-idiotype has been receiving the most attention in the 
development of new vaccines, also the Ab2γ seem promising in the induction of an 
anti-viral response. In fact, Bryson et al. 2008186 reported the crystal structure of the 
complex between the mouse antibody anti-HIV-1 Ab1/2F5 and its anti-idiotype 
Ab2/3H6 (wwPDB code: 3BQU), in which they showed that Ab2/2F5 does not 
resemble the structure of the original Ab1/2F5’s antigen, but still interferes with the 
Ag-Ab1 binding189, classifying the Ab2 as γ. Anyway, it is still uncertain if this 
information can concretely help the attempts at creating a vaccine targeting human 
immunodeficiency virus (HIV). 
 
The role of the anti-idiotypic antibodies in autoimmune diseases 
The idiotypic network has also a fundamental role in the autoimmune diseases. The 
regulation of the autoimmune response is still an intriguing and largely explored area. 
The factors leading to the onset of the autoimmune response remain obscure, but the 
idiotypic dysregulation is now recognized as a major mechanism for autoimmunity. In 
fact, in subjects susceptible to autoimmune diseases as a result of genetic 
predisposition and environmental factors, the immune response to a particular self 
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antigen involves an uncontrolled production of idiotypic antibodies (autoantibodies) 
that recognize pathogenic epitopes. Deficient idiotypic regulation of autoantibodies 
has been considered responsible for a number of autoimmune diseases190 such as 
systemic lupus erythematosus (SLE)191, autoimmune thyroiditis,192 systemic 
vasculitis193 and the Guillain-Barrè syndrome194. Furthermore, it has been 
demonstrated that autoimmune patients show a large ratio of autoantibody to anti-
idiotype concentration whereas this ratio is small in healthy controls.195 
Therefore, the use of anti-idiotype could be very promising in the study and the 
treatment of auto-immune disease. It is still very hard to find a definitive cure for this 
kind of diseases, due to the fact that the pathogen triggering the immune response is a 
self antigen, but in vivo study have indicated that anti-idiotypic antibodies might be 
able to downregulate the autoantibodies. In type 1 diabetes, for example, it was shown 
that anti-idiotypes may play a protective role in the immune response, by preventing 
that the auto-antibody binds its antigen.196 
Another important application is creating animal models to study autoimmune 
diseases, by inducing them in animals through the usage of pathogenic idiotypes of 
autoantibodies. Following immunization with Ab1 and production of Ab2, the 
animals develop Ab3 having original autoantibodies properties and are associated 
with the respective serological and clinical manifestations of the disease.168,197  
 
The celiac diseases 
One of the most common disease with autoimmune features that suffers from a lack 
of animal models is celiac disease (CD). It is a disorder affecting approximately 1 in 
100 individuals in the European population150 occurring as a result of the interplay 
between genetic and environmental factors.198 It is a long-life inflammatory condition 
characterized by flattering of the intestinal mucosa and malabsorption. The 
pathogenesis involves dietary exposure to gliadins, specific antigenic determinants 
found in gluten. The disease is characterized by presence of specific antibodies 
recognizing gliadins, food proteins and an endomysial autoantigen identified as tissue 
transglutaminase 2 (TG2).154 The antibody level against gliadins and TG2 increase 
upon exposure to gluten, and decrease during the course of a gluten-free diet. 
Although considerable scientific progress has been made in understanding celiac 
disease and in preventing or curing its manifestations, a strict gluten-free diet is the 
only treatment for celiac disease to date. 
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Recently, celiac antibodies recognizing TG2 have also been shown to elicit the 
production of anti-idiotypes antibodies in mouse.6 To the aim of developing an animal 
model in order to verify the possibility of expressing human anti-TG2 antibodies in 
vivo, Di Niro et all.6 injected in mice non predisposed to gluten-intolerance two anti-
TG2 antibodies isolated from patients with CD, both recognizing human TG2, but 
only one autoantibody (clone 2.8) is cross-reactive to mouse TG2. Since the other 
antibody (clone 3.7) does not recognize murine TG2, and so presumably had no in 
vivo immunological effect, it was used as a negative control.  
What they found was a clear proof of an anti-idiotypic response in mice treated with 
clone2.8 (the only one able to recognize mouse TG2), in which the production of anti-
TG2 antibodies was counterbalanced by the production of anti-Id antibodies. In 
particular, the results showed that all the anti-Id antibodies competed strongly with 
TG2 for clone 2.8 binding, indicating that both interact with the antigen-binding site. 
To the aim of better understand the role and the characteristics of the interaction 
between the autoantibody anti-TG2 and its anti-idiotype, the sequence of the anti-
idiotype antibody (AIT2) from mouse was characterized. 
 
Aim of the  work 
Due to the growing importance of anti-idiotype antibodies in the development of new 
strategies for the treatment and the study of celiac disease (and diseases in general), 
we believe that the characterization at atomic level of the interaction between the 
autoantibody anti-TG2 clone 2.8 (Ab1) and its anti-idiotype (Ab2) could be of great 
interest. For this reason, we performed docking simulation between the autoantibody 
clone 2.8 and its anti-idiotype AIT2 isolated from mouse. We also compared the 
obtained solutions with available experimental Ab1-Ab2 structures.171,186,188,199-201 
Finally, we searched for local structural similarities between the Ab2 and the original 




6.2 - Methods 
Abs modeling 
The variable domain structures of clone 2.8 and Ab2-mouse AIT2 were modeled by 
the RosettaAntibody Fv homology modeling server,164 using the full refinement 
protocol option.  
The PDB codes of the templates for Ab2 AIT2 are as follows: 1MH5 for the heavy-
chain framework (97,01%) and 1AY1 for the light chain (96,77%); 1AY1 for L1 
(100,00%), 1SEQ for L2 (100,00%), 1AY1 for L3 (77,78%); 1IQW for H1 (90,00%), 
1IQW for L2 (100%) and 1A2Y for H3 (same length, no identity).  
 
Docking 
The obtained models were then used for Ab1/Ab2 protein-protein docking 
simulations, performed by the ClusPro 2.0 server.56 By default, ClusPro server docks 
the receptor (Ab2) and the ligand (clone2.8) structures using DOT rigid-body docking 
algorithm. The top 20.000 complexes generated by DOT are then filtered according to 
electrostatic and desolvation energies, and then the top 2000 complexes are retained 
for further processing. The retained 2000 conformations are then clustered according 
to interface RMSD values and the top 10 docked models, following a short Charrm10 
energy minimization, are made available for download. In all the simulations, all the 
Ab2’s residues that do not fall into the Complementary Determining Region (CDR) 
were masked (ClusPro Antibody Mode). Differently, for clone2.8 two situations were 
explored. In the former, indicated as ‘blind’ docking, all the clone 2.8 residues were 
considered on an equal basis; in the latter, indicated as ‘active’ docking, all but CDR 
residues were marked, to have only CDR interacting.  
 
Analysis 
The representative structures of the ten best clusters for each simulation were 
analysed. To analyze the docking results we used the CONS-COCOMAPS5 web tool, 
that uses the conservation of inter-residue contacts as an estimate of the similarity 
between different docking solution. Then, the visualization and comparison of the 
interface in the docking models and crystallographic complexes were performed with 
the COCOMAPS4 web tool, through intermolecular contact maps. Finally, a local 
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structural similarity between the Ab2 and the original clone 2.8’s antigen TG2 was 
perfomed by RASMOT 3D PRO202 and ProBis 2012203 web tools. 
 
 
6.3 - Results and Discussion 
We performed docking simulations to obtain the structure of the complex between the 
idiotype clone 2.8 and its anti-idiotype AIT2, both isolated from CD patients. The 
structures of both Ab1 and Ab2 were reliably predicted by homology modeling using 
Rosetta Antibody,164 while protein-protein docking simulations were performed by 
ClusPro 2.0.56 
In our ClusPro Ab1-Ab2 simulations, Ab2-AIT2 acts as the antibody (i.e the 
recognizing molecule), while Ab1-clone2.8 acts as the antigen (i.e. the recognized 
molecule). Therefore, as generally done for antibodies, Ab2-AIT2 was fixed and all 
its residues not falling into the CDR were masked. As for the Ab1-clone 2.8, in a first 
‘blind’ docking approach, all residues were considered unmasked, and therefore 
available for the interaction. However, as experimental data showed that AIT2 
strongly competes with the original TG2 antigen for the clone 2.8 binding, indicating 
that it also binds to the clone 2.8 CDR region, we additionally ran ‘active’ 
simulations, where the non-CDR regions of clone 2.8 were masked. For each docking 
approach, we then analyzed the representative structure of the ten best clusters, that 
should capture most of the important rigid-body binding geometries, providing good 
starting structures for further analyses.  
 
‘Blind docking’ 
The ‘blind’ docking simulations gave solutions with relative low population (86/2000 
for the first cluster). However, although no constrains were applied, all the ten 
models, with the only exception of model 6, pointed to the CDR region of clone 2.8 




Figure 31. ‘Blind’ and ‘active’ docking clusters population and 3D visualization 
(a) and (b): Table reporting the population of the top ten clusters, and the score of the 
representative model of each cluster; the values are reported for both ‘blind’ (a) and  
‘active’ docking simulations (b). (c) and (d): Pymol204 visualization of the 
representative models of the top ten clusters in both ‘blind’ (c) and the ‘active’ 
docking simulations (d), after superimposition of clone 2.8. The clone 2.8’s light 
chain is colored in cyan, its heavy chain is colored in blue and its CDR loops are 
highlighted in dark blue. All the models involving the clone 2.8’s CDR region for the 
interaction have AIT2 colored in silver, while the only one pointing in the other 
direction has it colored in copper. 
 
Furthermore, running CONS-COCOMAPS5 on the top ten solutions, a significant 
consensus was found in terms of intermolecular contacts. In particular, CONS-
COCOMAPS5 gives in output: i) a ‘consensus’ map, i.e. a 2D map were inter-
molecular contacts are shown in a scale of grays were the more conserved the contact, 
the darker the spot, and ii) a list of the most conserved contacts.  
The consensus map (Figure 32a) showed at a glance the similarity among these ten 
best docking solutions; in fact, the map was not spread but the dark spots converged 
in well defined and conserved regions, most of them located at the crossover of the 
CDR loops of both clone 2.8 and AIT2. Please note that involvement in the 
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interaction of the clone2.8 CDR loops was not obvious as a result of the ‘blind’ 
simulations, where all its residues were treated on an equal basis. This consensus was 
also quantified by the CONS-COCOMAPS’ table that reports the list of the most 
conserved inter-residue contacts, in which it was evident that all the clone 2.8’s CDR-
loops were involved in the interaction in more that one model (reaching a maximum 
of seven models on ten having the L1 and L2 loops at the interface, and a minimum of 
three models on ten having the H1 at the interface, see Figure 32).  
 
 
Figure 32. Consensus maps and consensus lists 
 (a) and (b): The CONS-COCOMAPS consensus map between clone 2.8 and AIT2 
for the ten best ‘blind’ (a) and the ‘active’ (b) docking. Labels have been added for 
clone 2.8 CDR loops L1-L3 and H1-H3. (c) and (d): List of the number of models 
presenting the clone 2.8’s CDR loop at the interface of interaction, in the case of the 
‘blind’ and the active ‘docking’. 
 
So, overall the ‘blind’ simulation clearly show that the region recognized by the anti-






We therefore ran the ‘active’ docking simulation, where the CDR residues of clone 
2.8 were the only ones not masked in the docking. The results do not vary greatly. 
Comparing the ‘blind’ and ‘active’ consensus maps (see Figure 32a and b) it is 
apparent that the ‘active’ solutions represent a subset of the ‘blind’ ones. In fact, 
almost all the spots showed in the ‘active’ consensus map are included in the spots 
showed in the ‘blind’ consensus map, and darker in same cases. The first cluster 
coincides with the first most populated ‘blind’ solution and its population is about 
doubled (Figure 28a and Figure 28b). 
Analyzing and characterizing the interaction interface for these docking models by the 
COCOMAPS4 web tool, one preferred solution clearly emerges finding a significant 
consensus among the most populated ‘blind’ and ‘active’ solutions (and also the ones 
of lowest score), involving about 20% of all the solutions. In fact, by the comparison 
of the COCOMAPS4 contact maps it is apparent at a glance the overlap of the 
epitopes (corresponding in an overlap of the spots in the contact maps), in particular 
between model 1 of the ‘blind’ docking and model 1 and model 2 of the ‘active’ one 
(cluster population of 86, 152 and 118, respectively) (Figure 33). Also the 
resemblance of the accessible surface area in the three complexes, the lists of residues 
at the interaction interface and of the intermolecular H-bonds given by COCOMAPS4 
confirmed the similarity between them (data not shown). 
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Figure 33. Comparison of the COCOMAPS’s property contact maps and the 
CONS-COCOMAPS’s consensus map. 
(a), (b) and (c): the distance range contact maps by COCOMAPS4, calculated for the 
model 1 of the ‘blind’ docking (c) and model 1 (a) and model 2 (b) of the ‘active’ one. 
Labels have been added for clone 2.8 CDR loops L1-L3 and H1-H3. The dots at the 
crossover of two residues are colored in red, yellow, green and blue if any pair of 
atom is closer than 7, 10, 13 and 16 Å, respectively. (d) Consensus map calculated on 
the blind simulation’s model 1, active simulation’s model 1 and model 2. Also, labels 
have been added for clone 2.8 CDR loops L1-L3 and H1-H3. 
 
6.4 - Study of experimental cases from literature: comparison with 
other Ab1-Ab2 X-ray structures 
We than decided to analyze the features of the complex interface in all the available 
experimental structures of Ab1-Ab2 complexes (in the wwPDB: 1CIC,201 1IAI,171 
1DVF,199 1PG7,188 3BQU186; experimental structure of Ab1 YsT9.1 in complex with 
the Ab2 T91AJ5 determinated by Evans et al.,200 ) and to compared these with the 
AIT2-clone 2.8 ‘consensus’ complex we selected upon the docking simulations. We 
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found that there is one recurrent binding solution in the experimental structures, that 
interestingly closely resembles the one we found for clone2.8 and AIT2. This 
increases our confidence in the proposed orientation of the molecules in the complex.  
 
First, the RMSD between the experimental case and the proposed model is of only 3.2 
Å. In Figure 34 the contact maps of both AIT2/clone 2.8 ‘consensus’ model and the 
crystallographic structure between an anti-hen-egg-white lysozyme antibody (Ab1-
D1.3) and an anti-idiotypic antibody (Ab2-E5.2) (wwPDB code: 1DVF)199 are 
reported. Comparing the two contact maps, it is evident that the AIT2/clone 2.8 model 
provides similar binding interaction to the x-ray structure. In fact, both complexes 
seems stabilized preferentially by contacts between:  
- Ab1’s loops L1, L3 and H2 interacting with the light chain of Ab2; 
- Ab1’s loops L1, L2, L3 and H3 interacting with the heavy chain of Ab2. 
The chemical-physical nature of the interaction residue involved in the interaction 
seems similar among the two complexes, showing in both cases a major involvement 
of hydrophilic residues. In fact, using the COCOMAPS default cutoff value to define 
the interaction residues (i.e. 8 Å), the clone 2.8/AIT2 model present 68,6% of 
hydrophilic/hydrophilic interaction, similar to the 60,9% of D1.3/E5.2 x-ray structure. 
On the contrary, the percentage of hydrophobic/hydrophobic interaction is of 2,2% for 
the model and 4,2% for the experimental structure we are considering, in both cases 
centered on the Ab1’s H3 – Ab2’s H3 interactions. Also the number of intermolecular 
H-bonds results the same in both cases. 
Finally, we found similarity also in the values of the interface area, being of 816.4 Å2 





Figure 34. Comparison with x-ray 
(a) and (b): the distance range contact maps by COCOMAPS4, calculated for the 
clone 2.8/AIT2 model (a) and the experimental structure of E5.2/D1.3 complex (PDB 
code: 1DVF) (b). The dots at the crossover of two residues are colored in red, yellow, 
green and blue if any pair of atom is closer than 7, 10, 13 and 16 Å, respectively. (c) 
and (d): Pymol204 visualization of clone 2.8/AIT2 model (c) and the experimental 
structure E5.2/D1.3 (d). The color code is the same in both figures: the Ab1 light and 
heavy chains are colored in light and dark blues, respectively; the Ab1 light and heavy 
chains are colored in light and dark pink, respectively. Labels have been added for the 
Ab1’s and Ab2’s light and heavy chains.  
 
6.5 - Searching for structural similarities between Ab2 and Ag 
The last step in the characterization of a Ab1-Ab2 complex is to identify possible 
structural similarities between the anti-idiotype Ab2 and the original antigen TG2. 
Unfortunately an experimental structure for the TG2-clone2.8 complex (the 
corresponding Ag-Ab1 complex) is missing, therefore we could just search for a 
possible local structural similarity between Ab2 and the original Ab1’s antigen TG2. 
However the two web tools used to the aim, RASMOT 3D PRO202 and ProBis 




6.6 - Conclusion 
Here we report a molecular model of the complex between the mouse anti-idiotype 
antibody Ab2-AIT2 elicited against the celiac autoantibody Ab1-clone 2.8. The 
present investigation provides better picture and gives useful insight into the 
orientation and characterization of the complex’s binding site, showing that the 
interaction involves the Ab2-clone 2.8’s binding site specific for the original antigen 
TG2, in according with the experimental data. Unfortunately, the experimental 
structure for the corresponding Ag-Ab1 is missing, and the only searching for 
structural similarity between Ab2 and original Ab1’s antigen did not detect significant 
similarity. So, on the basis of this property, Ab2 can be classify the Ab2β or Ab2γ. 
The improvement achieved in recent years by methods for predicting structures and 
protein-protein interaction give us the confidence in the results of our computational 
approach. Most importantly, the model is validated by its ability to explain the 
experimental data, its coherence resulting by different docking simulations and by the 
comparison with experimental structure complexes of the same typology, resembling 
the most recurrent binding mode of the experimental Ab1-Ab2 complexes. 
Due to the crucial involvement of the idiotypic network in the autoimmune diseases 
and the promising therapeutic applications, the proposed model could help 
rationalizing the experiments as crucial step for the study of the celiac disease and the 





CHAPTER 7 - Dynamic properties of a pathogenic mutant 
of the blood coagulation Factor X activated (FXa) and their 




7.1 - Introduction 
As described in Chapter 1, protein-protein interactions are intrinsic to every cellular 
process. Protein complexes underline for instance signaling, regulation, immunogenic 
recognition, as well as post-transcriptional events.58 Apart from the antibody-antigen 
interactions described in Chapter 5 and 6, another fascinating biological complex 
typology is the one between an enzyme and its substrate. The enzymes are large 
proteins responsible for thousands of chemical interconversions occurring in the cells. 
An enzyme, in fact, acts as a highly selective biological catalyst, increasing the 
velocity and the rate of the reaction. Most enzymes act specifically with one reactant 
(called substrate) to produce products. On the basis of the function and the reaction 
that the enzymes catalyze, they are divided in families. A family of enzyme that is an 
interesting case in the field of the protein-protein interaction study is the serine 
protease one. These enzymes catalyze the cleavage of the peptide bonds in proteins 
and they are involved in a lot of fundamental processes, such as blood coagulations, 
digestion, immune response and reproduction. There are many experimental data 
available about the structure, the nature of the binding site (made of the catalytic triad 
His, Asp and Ser) and the function of the serine protease that helps to carry out 
structural study. In this scenario, my group and I focused the attention on a study 
about the recognizing properties of the serine protease factor X and its pathogenic 
mutant that causes problems in the blood coagulation cascade, taking advance of the 
molecular dynamics technique.  
 
Factor X 
The factor X (FX) is a vitamin K-dependent glycoprotein synthesized in the liver as a 
precursor molecule.71,72 FX plays a pivotal role in the coagulation cascade being the 
point of convergence between intrinsic and extrinsic pathway of blood coagulation. 
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The FX activation results from the cleavage of the peptide bond Arg194-Ile195 
(Arg15-Ile16 in the chymotrypsinogen numbering) that transforms the inactive 
zymogen of FX in a fully active enzyme (FXa). Upon its activation, FXa assembles 
into the prothrombinase complex to convert prothrombin (its substrate) to thrombin in 
the final stage of the blood coagulation cascade.205,206 
FX circulates in plasma, at a concentration of 8-10 µg/mL, as a two chain protein: a 
light chain of 17 kDa linked with a disulphide bond to a 45 kDa heavy chain. FX 
shares extensive amino acid sequence identity to other vitamin-K-dependent serine 
proteases such as prothrombin, FVII, FIX, protein C and protein S.207 In particular, 
the catalytic sites of the hemostatic proteinases share the same fold of the trypsin-like 
serine proteinases.208 This allowed the use of the chymotrypsinogen numbering 
system for residues of the catalytic domains, which facilitate comparison of the 
various factors. The FXa catalytic domain is composed of two six- strand β−barrels 
and four short helices. The three serine protease catalytic residues His57, Asp102 and 
Ser195 (chymotrypsinogen numbering) are located at the crevice of the two β−barrels 
(Figure 35). The catalytic Ser195, together with the adjacent Gly193, forms the 
“oxyanion hole”, helping to stabilize the tetrahedral intermediate during catalysis. 
Inherited FX deficiency is a rare (1:1,000,000) coagulopathy with severe bleeding 
symptoms presenting early in life in homozygous patients.209,210 About 105 causative 
mutations have been described in the FX gene so far, the majority of which are 
missense. The study of naturally occurring mutants in FX offers considerable insight 
into the structure and function of FX molecule. However, only few FX mutants have 
been expressed and characterized so far, and among them, only four located in the 
catalytic domain, were analyzed, namely Val342Ala, Arg347His, Gly366Ser and 
Gly381Asp.8,211-213 Expression studies showed that all recombinant proteins were 
normally synthesized and secreted, but further functional characterization revealed 
that all of them had reduced coagulant activity, even those having a rate of activation 
similar to the wild type protein. All these studies confirmed the existence of a strict 
correlation between the localization of the mutation and protein function.214 
 
In the present study, my group and I focused our attention on the molecular 
characterization of a recurrent p.Gly262Asp mutation (Gly43Asp in the 
chymotrypsinogen nomenclature; to better localize the amino acid residues in the 
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molecular modeling of the mutant FX, the chymotrypsin numbering system was used 
throughout the text) in the catalytic domain of mature FX protein, performing 
molecular dynamic simulations. We performed the present investigation to the aim of 
provide an explanation about the influence of the mutation on the structure and 
function of the protein ant its consequence on the interaction with the substrate. The 
study was conducted in collaboration with the experimental groups of the Prof. De 
Cristofaro (Hemostasis Research Centre, Institute of Internal Medicine and Geriatrics, 
Catholic University School of Medicine, Rome, Italy) and Prof. Peyvandi 
(Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Università degli 
Studi di Milano and Luigi Villa Foundation, Milan, Italy), that performed in vitro 
expression analyses and steady state kinetic studies of the wild type FXa and of its 
Gly43Asp mutant. The current name of the mutation refers to initiating methionine 
numbered as +1, but it was originally reported as Gly222Asp.215 Gly43 is a buried 
residue located in the β3-strand (residues 40-46) of the N-terminal β-barrel, under the 
oxyanion hole formed by the Ser195 and Gly193 residues. It also gives an H-bond 
with the Ser195 backbone. Its spatial position relative to the catalytic triad is pretty 
fixed, as a disulphide bridge connects the immediately upstream Cys42 to Cys58 that 
follows the catalytic His57 (Figure 35). 
Therefore, to investigate the effect of the naturally occurring Gly43Asp mutation on 
the FXa structure and dynamics, in vitro expression analyses, steady state kinetic 
studies and molecular dynamics (MD) simulations of the wild type FXa and of its 
Gly43Asp mutant were performed. This is the first report of the cellular fate 
characterization of a mutation located in the so-called loop-40 of the FXa, a 




Cartoon representation of the crystallographic structure of the catalytic domain of 
human FXa (PDB code: 2BOH). In this orientation, the N-terminal β-barrel is up 
(colored gray) and the C-terminal β-barrel is down (colored copper). Gly43 and the 
catalytic residues are shown as red and yellow sticks, respectively. The bound 
calcium ion and oxygens of the two crystallographic waters close to Gly43 are shown 
as large magenta and small red spheres, respectively. The H-bond between Ser195(O) 
and Gly43(N) is also shown and a stick representation of the Cys42-Cys58 disulfide 
bridge is given. 
 
 
7.2 - Methods 
Molecular dynamics simulations and electrostatic potential calculations 
For the MD simulations of FXa, the 2.2 Å resolution crystal structure corresponding 
to the PDB code 2BOH217 was selected. For the MD simulations of the heavy chain of 
FXa, the 2.2 Å resolution crystal structure corresponding to the PDB code 2BOH was 
selected.218  Since missing crystallographic waters may lead to artifacts in the FXa 
dynamics,219 we selected a starting structure with a large set of well- determined 
water molecules,217 which were included in the simulations. Interestingly, in the X-
ray structure two buried water molecules are located close to the Gly43 residue. The 
starting structure for the FXa43Asp mutant was generated by the Mutagenesis PyMol 
module.96 Insertion of the quite bulky aspartate side chain did not cause any dramatic 
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clash with the rest of the molecule, and the oxygens of the carboxylate group replaced 
the two aforementioned crystallographic waters. 
 
All the MD simulations were performed using GROMACS ver. 4.5.4 220 that adopts 
the AMBER99SB221 force-field for energy minimization and molecular dynamics 
simulations. Both the WT and MT structures were solvated in a periodic cubic box 
with about 12500 TIP3P222 water molecules, and at least 10 Å between the protein 
and the box sides. Electroneutrality was achieved by random replacement of water 
molecules with enough counter ions. The Particle-Mesh Ewald algorithm was applied 
to treat electrostatic interactions. The systems were first energy minimized, then a 
short 100 ps NVT MD simulation at 300 K was run to equilibrate them. These 
structures were used as the reference in the analysis of the MD trajectories. For better 
sampling, four different 60 ns long NPT MD simulations for each protein were 
performed assigning different initial velocities. A Berendsen thermostat with a time 
constant of 0.1 ps was used to control temperature of protein and of solvent. Pressure 
was controlled with a Parrinello-Rahman barostat with a time constant of 2 ps. The 
time step of the simulations was set to 2 fs, coordinates were saved every 10 ps. 
Analysis was performed on the last 10 ns. 
Structural properties, such as root mean-square deviation (RMSD), root-mean square 
fluctuation (RMSF) and hydrogen bond interactions, were calculated with the built-in 
functions of GROMACS. Essential dynamics analysis was based on the 
diagonalization of the covariance matrix of the protein alpha-carbon atomic 
fluctuations. To calculate the H-bonds occupancy, the cut-offs on the Donor-Acceptor 
heavy atoms distance and on the Hydrogen-Donor-Acceptor angle were set at 3.5 Å 
and 30°, respectively. A representative structure for each system was also extracted, 
to be used for visualization and electrostatic potential calculations, by selecting the 
nearest frame to the average coordinates during the last 10-ns. Electrostatic potentials 
were calculated by solving the Poisson-Boltzmann equation using the APBS program 
223 and visualized with PyMOL 224. Calculations were carried out on a grid spacing 
between 0.31 and 0.37 Å, with a temperature of 298.15 K. The dielectric constrants 
were set to 4 for the protein and to 78 for the solvent. The solvent probe radius used 
was 1.4 Å.  
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7.3 - Results 
To investigate the effect of the naturally occurring Gly43Asp mutation on the FXa 
structure and dynamics, we performed molecular dynamics (MD) simulations of the 
wild type FXa (WT) and of its Gly43Asp mutant (MT). We selected a starting 
structure with a large set of well-determined water molecules 217, which were included 
in the simulations. Interestingly, in the X-ray structure two buried water molecules are 
located close to the Gly43 residue. When we modeled the Gly43Asp mutant, the 
insertion of the quite bulky aspartate side chain did not cause any dramatic crash with 
the rest of the molecule, and the oxygens of the carboxylate group replaced the two 
above crystallographic waters.  
 
RMSD and RMSF analysis 
Four 60-ns-long MD simulations have been performed both for the WT and MT FXa 
with different initial velocities, to ensure better sampling. The overall stability of the 
proteins throughout the simulations were monitored through the RMSD of Ca atoms 
from the appropriate starting structures for each of the eight simulations. The systems 
remain stable during the 60-ns both in WT and MT (see Figure 36), and reach the 
equilibrated structures after 30-ns of simulation time based on the pleateuing of the 
RMSD curves, both for the WT and MT simulations. 
To investigate how the mutation affects the overall flexibility of the protein, we also 
calculated the RMSF of the C-alpha atoms during the last 10-ns of the simulations 
(Figure 36). The Cα-RMSF values reveal the same trend among the four different 
simulations for each system. The trend and overlap of the RMSD curves and also of 
the RMSF profiles are clear indicators of the similarity between the spaces sampled 
by the four simulations for both the systems. Due to convergence of these simulations, 




Figure 36.  
The time dependence of RMSDs for the Cα of WT (on the left) and MT FXa (on the 
right) in the 60-ns MD simulations. The four simulations are shown in different colors 
in both the WT and MT systems. 
 
From the RMSD values and the RMSF trends (Figure 37c), it is apparent that the 
Gly43Asp mutation does not dramatically affect the FXa structure, neither globally 
nor locally. This is also confirmed by the conservation of the secondary structure in 
the two systems, monitored during the last 10-ns of MD simulation (data not shown). 
It is worth noting that the fluctuation of residue 43, both in WT and MT is particularly 
low (see Figure 37c). As already said, this is related to the presence of a disulphide 





The calculated RMSF of Cα atoms vs protein residue number during the last 10-ns of 
simulation for : a) WT and b) MT FXa. The four simulations are shown in different 
colors in both the WT and MT systems. c) A comparison between the RMSF plot for 




Catalytic hydrogen bonds 
A notable difference between the two systems is however observed, when looking at 
the protein H-bonds. Interestingly, on average four more H-bonds are found in the 
MT as compared to the WT (total number 167,4 vs. 163,6). To investigate whether 
this involve the catalytic site, all the H-bonds involving the catalytic triad and/or the 
Gly/Asp43 residue were monitored during the last 10-ns of the MD simulations. In 
Table 12, the occupancy of these “catalytic H-bonds” is reported for WT and MT; in 
Figure 38a view of the “catalytic H-bond network” is also given for the two systems. 
 
Acceptor Donor WT G43D mutant 
43D/G(O) T54(OG1) 97,9 0,0 
43D(OD1) Q30(NE2) - 100,0 
43D/G(OD2) F141(N) - 98,6 
S195(O) 43D/G(N) 98,7 66,2 
D102(OD1/OD2) H57(ND1) 86,5 95,7 
D102(OD1/OD2) H57(N) 99,0 96,9 
H57(O) Y60(N) 73,2 70,3 
H57(NE) S195(OG) 0,3 11,8 
D102(OG) T229(OG) 97,2 1,7 
D102(OD1) S214(OG) 99,4 99,7 
D102(O) A56(N) 2,3 81,1 
S195(OG) G193(N) 12,8 19,3 
S214(O) S195(OG) 0,8 29,2 
I227(O) S214(N) 81,1 78,9 
A104(O) T54(OG1) 0,0 69,3 
Table 12 
The occupancy percentage (%) of WT and MT FXa hydrogen bond interactions 






The H-bonds network around the catalytic site, as calculated during the last 10-ns of 
simulation for WT (on the left) and MT FXa (on the right). H-bonds which are 
remarkably different between the two systems are shown in red, those conserved are 
instead shown in blue. The mutated residue (Gly/Asp43) is colored red, the catalytic 
triad is colored yellow. Remaining residues are colored gray if belonging to the N-
terminal and copper if belonging to the C-terminal β-barrel. Note that for the sake of 
simplicity, the Gly193(N)-Ser195(O) H-bond, whose occupancy is comparable 
between the two systems, is not reported. 
 
Both from Table 12 and Figure 38, it can be easily seen that the mutation modifies the 
H-bonds network around the catalytic residues, by thickening it in the MT, as 
compared to the WT. In particular, in the WT the Gly43 backbone acts as acceptor in 
a high-occupancy H-bond with the side-chain of Thr54. Such H-bond is lost in the 
MT, however it is here compensated by a H-bond between the Thr54 side chain and 
the Ala104 backbone (see Figure 38). Importantly, MT Asp43 uses its additional H-
bond acceptors (the oxygens of the carboxylate group) to give two novel H-bonds, as 
compared to the WT, with the side chain of Gln30 and with the backbone amide 
proton of Phe141 (from the opposite C-terminal β-barrel), respectively. It is 
interesting that one of these H-bonds substitutes a WT H-bond involving the Phe141 
backbone and one of the above crystallographic waters.  
As a possible conseguence, the backbone-backbone H-bond between residue 43 and 
the catalytic Ser195, which is very stable in the WT (occupancy 98.7%), becomes 
weaker in the MT (occupancy 66.2%). Other two ”catalytic H-bonds” are also 
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significantly affected by the mutation: one involves the side chains of His57 and 
Ser195, while the other involves the Ser195 side chain together with the Ser224 
backbone. Both these hydrogen bonds are observed in a significant fraction of MT 
structures (occupancy 11.8 and 29.2%, respectively), whereas they are absent in the 
WT (occupancy below 1%). Finally, a backbone-backbone H-bond between the 
catalytic Asp102 and Ala56 is observed in the MT, instead of the side chain-side 
chain H-bond between Asp102 and Thr229 of the WT. 
 
Essential dynamics 
It is commonly accepted that essential degrees of freedom (or correlated motions) of a 
protein describe motions relevant for its function,31-33 with the first several 
eigenvectors normally representing most of the correlated motions.31 Therefore, 
essential dynamics analysis was carried out on the C-alpha  atoms of wild type and 
mutant FXa. For both systems, the last 10 ns trajectories were projected onto their 
eigenvectors and the RMSF curve of the C-alpha  atoms of the protein along the first 
eigenvector was plotted (Figure 39a). The regions show similar fluctuation for wild 
type and mutant, except in same peripheral parts of the proteins and in a region 
involved in the binding of the substrate. Specifically, the loop containing residues 94-
97, at the border between the S2 and S4 binding pockets, shows a larger correlated 





a) Comparison of the RMSF curves for the Cα atoms of WT (black line) and MT FXa 
(red line) along the first eigenvector. b) Cα ribbon representation of the ensemble 
structures representing the movement of the first eigenvector for WT (colored blue) 
and MT. (colored magenta). The Cα atoms of Gly/Asp43 and of the catalytic triad are 
shown as red and yellow balls, respectively. Binding regions showing a different 
behavior in terms of correlated motions are also indicated. 
 
Electrostatic potentials 
To investigate the possible effect of the negative charge introduced by Asp43 in the 
MT, in proximity of the catalytic site, we also calculated continuum Poisson-
Boltzmann electrostatic potentials for the two systems. 
In Figure 40, representative structures are shown for WT and MT FXa, colored 
according to the calculated electrostatic potentials. The structures are oriented with 
the N-terminal and C-terminal β-barrels up and down, respectively. The crevices 
hosting the substrates are in the middle and cross the proteins horizontally. It is 
apparent that the potential along the crevice is predominantly negative for both the 
systems. However, in the MT the negative character of the electrostatic potential 
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around the active site is accentuated and, importantly, in correspondence of the 




Representative structures are shown for WT and MT FXa, with the Van der Waals 
surface colored according to the calculated electrostatic potentials. The crevice 
hosting the substrate crosses the proteins horizontally. The color scale (in kT/e) is also 
reported. A yellow circle is used to indicate the position of the oxyanion hole.  
 
 
7.4 - Discussion  
Several natural FX variants due to missense mutations were previously reported in the 
literature.206,207 These FX mutants, through different molecular mechanisms, are 
responsible for mild to severe reduction of FX procoagulant activity but only a few 
naturally occurring variants have been characterized so far. Hence, functional 
consequences of the majority of them remain largely unexplained. In addition, among 
naturally occurring FX mutations, only those compatible with normal or reduced 
biosynthesis and secretion are appropriate tools to investigate the molecular 
mechanisms underlying the disease, the structure-function relationships and bleeding 
tendency.  
Previous in vitro expression studies were performed only on 10 mutations (out of the 
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82 missense mutations hitherto identified); each of these studies elucidated the effect 
of the mutation, providing information on the involved molecular mechanisms. In 
particular, those located in the catalytic domain, Val342Ala [Val160], Gly366Ser 
[Gly183] and Gly381Asp [Gly197] mutations, led to normally synthesized proteins 
with variable reduction of the activity due to the disruption of the native 
conformational structure of the catalytic domain with rearrangements of the 
molecule,8,211,213 except for Arg347His [Arg165] that provokes the attenuation of FVa 
binding.212 All these mutations but Val342Ala [Val160] are predictive of a clinically 
severe FX deficiency characterized by absence of FX procoagulant activity.  
This work provides information about one of these naturally-occurring recurrent FX 
variants, the Gly43Asp mutation, that was firstly identified in two patients from 
Iran,17 and subsequently in 13 other patients from Turkey (unpublished data). All of 
them had a severe clinical phenotype, with such symptoms as hematomas and 
hemarthroses, hematuria and epistaxis, associated to a coagulant activity <1%.209 
The Gly43 is a buried residue at the core of a completely inaccessible β-strand  in the 
mature FX protein. The Gly43Asp substitution occurs at the highly conserved 42-58 
residues region (loop-40) shared among all trypsinogen-like proteins (Table 13). In 
addition, Krawczak et al., through a homology modeling study of the catalytic domain 
of the ancestors of the present-day serine proteinases, showed that sequence and 
structure of this region is maintained despite the processes of duplication and 
divergence that the genes coding for coagulation proteins have undergone during their 
evolution.225 These findings emphasize the importance of the loop-40 in the context of 




Aminoacids sequences from residue 42 to 58 (chymotrypsin numbering) of thrombin, 
FXa, FIXa and FVIIa and anticoagulant protein C. 
 
 124 
Mutations occurring at this region have been shown to be causative of severe type I 
prothrombin, FVII, FIX or protein C deficiency.226-229 The mechanism responsible for 
the severe FX deficiency caused by the Gly43Asp substitution was previously 
investigated showing a partial defect in secreting FX43Asp. Then, the experimental 
part of the present study on FX43Asp confirmed a secretion defect due to an 
alteration in the secretion efficiency of the mutant recombinant protein.  
It is clear that in the process of secreted proteins is orchestrated by a group of 
molecules with a quality control function. The proteins involved in the folding system 
are lectins such as calreticulin, calnexin and Erp57.230 These molecules (chaperons) 
facilitate protein folding231 and ensure that correctly folded, assembled and modified 
proteins are transported along the secretory pathway. Therefore, the partial defect in 
secreting FX43Asp probably occurs due to the introduction of a charged hydrophilic 
Asp residue instead of a neutral Gly into the protein core, altering the recognition site 
involved in the intracellular trafficking. 
In order to understand why the reduced amount of secreted mutant protein did not 
conserve its procoagulant activity, additional kinetic studies were performed in this 
study. In fact, the Gly43Asp substitution seemed to affect the amidolityc activity of 
the FX protein. These findings suggested that the Gly43Asp substitution does not 
totally disrupt the architecture and thus the catalytic function of the enzyme 210 but 
causes a more discrete change of the active site conformation. The Gly43 residue is 
sunk in the core of the protein, and is far from binding sites known to directly interact 
with substrates and/or cofactors to facilitate the specific assembly of the coagulation 
activation complexes.232,233 Gly43 is also located at the N-terminus of the region 
referred to as loop-40, an exosite strongly conserved in the family of serine proteases.  
Usually, a single point mutation affecting the activity of an enzyme is expected to 
compromise its native fold. However, our MD simulations clearly indicate that the 
Gly43Asp mutation neither disrupts nor destabilizes the FXa native structure. Rather, 
it makes it someway more rigid, by thickening the H- bonding network around its 
catalytic site and by affecting the correlated motions involving the substrate binding 
site. This should not be surprising, considering that the mutant shows a residual 
catalytic activity that would be incompatible with a completely misfolded protein. 
Moreover, it is now definitely established that enzymes have evolved under 
synergistic pressure between structure and dynamics and that their motions underlie 
catalysis.234 Experimental evidences for the correlation between the dynamic 
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flexibility of the active site and its catalytic activity have also been specifically 
collected for α-chymostrypsin, a prototype serine protease.235 Therefore, 
compromising the FXa enzyme flexibility, the mutation may also compromise its 
catalytic efficiency. The increased rigidity of the mutant FX might also affect the 
molecular recognition by chaperone proteins inside the cell, thus causing the retention 
and defective secretion. Further, we have shown  that introducing a negative charge 
(Asp43) spatially close to the FXa catalytic Ser195, results in a negative electrostatic 
potential around the oxyanion hole, where the negative charge of the tetrahedral 
intermediate needs to be accommodated and stabilized. This is also expected to 
dramatically affect the enzyme catalytic efficiency. 
 
 
7.5 - Conclusion 
In conclusion, this work was focused on the study of the structural and functional 
aspects of a severe FX deficiency due to the frequent Gly43Asp mutation occurring at 
a highly conserved region (residues 42-58) shared among all trypsinogen-like 
proteins. This region of the FX protein has never been studied before and the 
replacement of the Gly43 by an Asp is like to cause a stiffening of the protein due to 
an altered distribution of H-bonds network as well as to a change of the electrostatic 
potential around the active site. These structural changes, although not dramatic, lead 
to the impairment of protein secretion and to a drastic reduction of its coagulant 
activity, proved by kinetic studies performed by the laboratories of the Prof. De 
Cristofaro and Prof. Peyvandi.  




APPENDIX 1 - Differences between membrane and soluble 
protein loop structures 
 
During the third year of my, I spent seven months in the group of Prof. Charlotte 
Deane, Department of Statistics, University of Oxford (UK). In this period I studied 
the geometrical features of the proteins’ regions most recurrent in the protein-protein 
interaction, the loops, clarifying some structural aspects of them in one of the most 
important and huge class of proteins: the membrane proteins. Here below there is the 
description of this work.  
 
Introduction 
Membrane proteins (MPs) represent about one third of all known proteins. They 
regulate the transport of molecules and information into and out of every living cell. 
Due to their involvement in many medically relevant processes, they comprise over 
half of current drug targets.236 
Unlike globular soluble proteins (SPs), whose natural environment is an aqueous 
solution (such as the cytoplasm), MPs sit inside a lipid bilayer. Thus, a large 
proportion of a MP's amino acids are in direct contact with the hydrophobic fatty acid 
tails of the membrane lipids. The presence of the membrane around the protein 
creates a very different physicochemical environment that has direct effects upon a 
MP's three-dimensional (3D) structure. Transmembrane (TM) segments are usually 
one of two structure types: α helices or β strands. These TM segments are connected 
to each other by stretches of amino acids with irregular structure, known as loops. 
Especially in helical TM proteins, the geometry of secondary structure elements is 
often well conserved, with approximately parallel helices being oriented 
perpendicular to the membrane plane (parallel to the membrane normal) and spanning 
the entire width of the membrane. The structure of the loop regions connecting the 
TM segments can vary greatly between homologues.237 Therefore, loops tend to be 
the parts of MPs that are the hardest to model. 
In MPs loops can interact with the polar head groups of the membrane lipids as well 
as with water molecules and thus tend to contain many hydrophilic and charged 
residues. Positively charged amino acids such as Lys and Arg are especially common 
in loops protruding into the cytosol (the positive inside rule).238,239 In addition to their 
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chemical properties, MP loops can also be expected to have characteristic shapes. The 
typical MP loop connects two roughly parallel TM segments and protrudes from the 
membrane into a polar environment. 
Due to the physical crowding of the membrane, the loop tends not to interact with 
other parts of the protein, except other loops, but might be found touching the polar 
head groups of the membrane lipids. Loops in SPs, on the other hand, can interact 
with sequentially distant residues and often lie on the surface of the protein rather 
than protruding from it. 
 
Due to the biological and medical importance of membrane proteins, they have 
become a major focus in structure prediction. Nevertheless, there is a lack of fast and 
reliable methods that specialize in modeling of membrane protein loops. Often 
methods designed for soluble protein are directly applied to membrane proteins, but 
obviously the difference between the structures of membrane and soluble protein 
loops influences their accuracy. 
The group of Prof. Deane has showed an evidence of this difference, and how this can 
influence the performance of a structure prediction. In fact, using FREAD240 program 
for loop modeling they have found that it is possible to predict accurately the structure 
of membrane protein loops using database of membrane protein fragments, (achieving 
an accuracy of 0.5-1 Å median RMSD), rather than using fragments of soluble 
proteins (achieving on accuracy of only 1-4 Å median RMSD). In fact, they found 
many fragments of soluble proteins with similar shapes to their membrane protein 
counterparts but with a very different sequence.  
The aim of my work in the Prof. Deane’s group was of exploring the reasons for the 
membrane and soluble protein loops difference by analyzing statistical and 
geometrical properties of both classes of loops. I have identified two features of loop 
structures that appear to differ between membrane and soluble proteins: the angle 
between the loop and flanking helices, as well as the contacts between residues and 





To understand how the conformations of membrane and water-soluble loops differ, I 
performed a series of tests on two sets of loops. 
 
Test set 
This study uses two sets of X-ray structures: one containing only water-soluble 
proteins (SPs), another containing only membrane proteins (MPs). An initial list of 
potential MPs was culled from PDB_TM241. An initial list of potential SPs was 
created using PISCES server242 under the below criteria: 
- Only X-ray crystallographic determined structure 
- Resolution ≤ 3Å 
- R-factor ≤ 0.3 
- Each chain sharing less than 99% in sequence identity 
For both sets, residues annotated by JOY243 as being anything but helices and sheets 
were treated as loop residues. For the MPs, only loops within the membrane, or close 
to it, were considered. Loops close to the membrane were defined as those residues 
less than 40Å from the central plane of the membrane.244 For each loop length, loops 
were clustered by sequence identity and made non-redundant at the 40% identity 
level. Lengths range from 3 to 15 residues. Only loops connecting two helices were 
considered. 
 
Loop angle θ 
I calculated the loop angle θ, which we define as the angle between the “loop” plane 
and the “helix” plane. First, the centres of mass (average co-ordinates) of the loop and 
the helices were calculated (the points labelled as “A” and “B” in Figure 41, 
respectively). To calculate the centre of mass of the “loop” A, all the Cα atoms of the 
loop were used, while to calculate the centre of mass of the “helices” B the Cα atoms 
of the six residues before and after the loop in the sequence were considered. The 
loop plane was defined as the plane passing through the two anchor residues (points 
labelled “C” and “D” in Figure 41) and the centre of mass of the loop A. In the same 
way, the helix plane was defined as the one passing through the two anchor residues 
and the centre of mass of the helices B. The loop plane’s orthogonal vector “a” and 
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the helix plane’s orthogonal vector “b” were calculated as the cross product between 
the vectors AC◦DA, and CB◦BD, respectively (Figure 41b). 
a = AC◦DA 
b = CB◦BD 
Finally, the angle θ was calculated using the scalar product between the two 
orthogonal vectors a and b, which corresponds to the angle between the helix plane 




Geometrical representation of a loop connecting two helices. A) side view, B) front 
view. The two red points “A” and “B” correspond to the loop’s centre of mass and 
helices’ centre of mass, respectively; the two red lines are the side projection/section 
of the loop plane and helix plane; the blue points “C” and “D” correspond to the 
positions of the two anchor residues’ Cα atoms; the green vectors “a” and “b” are the 
orthogonal vectors of the loop plane and helix plane, respectively, that are pointing 
out of the page plane. The angle θ between the two planes is also indicated. 
 
Contact number Ncontact 
For each residue in the loop, the number of residues within a cut-off distance of 4Å is 
calculated (only backbone atoms N, Ca, C, O are considered). Potentially interacting 
residues include any residues that are outside the loop itself and are further than two 
residues from the beginning and end of the loop along the protein sequence. Ncontact is 
defined as the number of contacts between the loop and its surroundings (where any 
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particular pair of residues counts only once), divided be the total number of loop 
residue is in contact. Ncontact can be interpreted as the average number of residue than 
an interacting loop residue is in contact with. A higher Ncontact would indicate tighter 
contact, i.e. any single interacting loop residue in closely surrounded by many 
sequentially distant residues.  
 
 
Results and Discussion 
The hypothesis developed in the Prof. Deane’s group was that the shapes of 
membrane loops tend to be biased, due to the presence of nearly parallel TM 
segments and the crowded environment of the membrane lipids. We propose that MP 
loops will favour a straight conformation, sticking out of the membrane, away from 
the remainder of the protein’s transmembrane domain. In contrast, while some SP 
loops might have similar shapes, they are not confined by the membrane and will be 
more often able to “lie down” on the surface of the protein, in contact with 
sequentially distant residues, thus forming a more globular shape. 
In order to test this hypothesis, I performed several tests on datasets of membrane and 
soluble protein loops. All loops, in both datasets, connected two helices. The first 
measure to assess this hypothesis is the loop angle θ, which is calculated as the angle 
between the plane of the loop and the plane of the two adjacent helices (Figure 41). 
We expected SPs to have a wide variety of θ angles, perhaps biased more towards a 
“lying down” conformation (larger θ values), we expected MPs to be biased towards a 
“straight” conformation (smaller θ values). We did indeed observe such a bias in 
loops up to 6 residues in length (Figure 42a), although only length-6 loops achieved a 
significant P value (p < 0.05) in a Kolmogorov-Smirnov test. MP loops have smaller 
θ angles than SP loops, indicating that they tend to “stand straighter”, away from the 
protein, than the average soluble loop. Loops with lengths above 6 residues showed 
no clear difference. One concern was that this might be due to the way we calculate 
the angle θ. Given that our definition of θ includes the center of mass of all loop C-
alpha atoms, longer loops might produce unpredictable behaviours. I thus repeated the 
calculations while calculating θ by only considering the first and last loop residue. 
The results obtained were virtually identical to the previous test (Figure 42b). While 
this validates our results, it also raises an interesting point: the difference observed in 
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the θ angles for short MP and SP loops (≤6 residues) is entirely due to changes in the 
conformation of the first and last loop residues. 
 
Figure 42. 
Loop angle θ vs loop length. A) Angle θ calculated using the centre of mass of the 
entire loop; B) Angle θ calculated using the centre of mass of only the first and last 
loop residue. 
 
I also investigated a second feature of membrane and soluble protein loops, namely 
their contacts with the rest of the protein. For this purpose I defined the contact 
number Ncontact (see Methods). A high contact number indicates “tight” contacts, 
where a single loop residue is in contact with many residues in the rest of the protein, 
a contact number close to 1 indicates “loose” contacts, where a single loop residue is 
in contact with only a single residue in the rest of the protein. We would expect MP to 
have lower average contact numbers, since their loops tend to stick out of the 
membrane, away from the bulk of the transmembrane domain. SP loops are expected 
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to have higher contact number, as they are not constrained by the membrane and can 
bend to be in closer contact with the bulk of the globular protein. On average, we do 
observe a small difference in Ncontact between MP (Ncontact = 1.53) and SP loops 
(Ncontact = 1.60). As Figure 43 shows, Ncontact tends to be smaller for MP loops when 
compared to SP loops of the same length, although some loop lengths show identical 
behaviour in the two datasets. Given the low numbers of example in the case of MP 
loops it is unlikely that this fluctuation is meaningful. We assume that, as more MP 
structure become known, this curve will smooth out to resemble that of SP loops, but 




Contact number Ncontact vs loop length in membrane proteins (MP) and soluble 
proteins (SP). 
 
I performed further investigations into the differences between the shapes of MP and 
SP loops. My results indicate a difference in the average conformations of the first 
and last loop residues resulting in a difference in loop angle θ. Short MP loops of up 
to 6 residues in length tend to have a lower θ, meaning they “stick out” away from the 
rest of the protein, rather than lying flat against it. We also observed a difference in 
the contacts between MP or SP loops and the remainder of the protein (Figure 43). 
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The results suggest that MP loops are more loosely connected to the rest of the protein 




It thus seems that the loop sequence, shape of the first and last residues, as well as the 
loop’s contacts with the remainder of the protein all contribute to the difference 
between MP and SP loops. It should be possible to engineer a statistical scoring 
scheme that utilizes measures similar to those defined here to identify fragments of 
soluble proteins that can be used to model the shape of membrane protein loops. 
This is the first case in which a parameter to define, describe and quantify the 








Due to the importance of protein-protein interactions in nature and the difficulty to 
obtain experimental data about the 3D structure of such complexes, the interest in 
protein docking is growing within the scientific community, and is currently one of 
the major challenges in the field of structural computational biology and 
bioinformatics.36  
 
As described in Chapter 1, the docking technique has the task of assembling two 
separate protein components into their biologically relevant complex structure giving 
a model of the way the two proteins bind each other.38,39 
Computational docking, if accurate and reliable, can therefore play an important role, 
both to infer functional properties and to guide new experiments. So, to its potential 
applications generating models of molecular complexes, although being a demanding 
problem, has attracted a vast deal of attention.40  
There are no general rules to predict a binding interface. Basically, all docking 
approaches assume that the native complex is near the global minimum of the energy 
landscape. Therefore, all the current docking methods are based on optimization and 
attempt to find the global minimum of a function approximating the free energy of the 
complex. For details see Chapter 1. 
 
Docking steps 
In all the docking algorithms, there are two crucial steps to generate possible models 
of the three-dimensional arrangement of a complex:  
 
3. Searching (low-resolution search), consisting in the generation of thousands 
of alternative poses (decoys) to sample the rotational/translational space; 
 
4. scoring and ranking (high-resolution refinement), consisting in scoring these 
poses using a ‘pseudo-energy’ function in order to rank the poses and so to 
identify the native-like solutions. 
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Sampling the conformational space 
The searching step involves an exhaustive search of the conformational space of one 
protein with respect to the other, resulting in a six-dimensional search (6D). The 
search of through the entire conformational space of the complex geometry makes the 
calculation expensive, so it is necessary to simplify the system. 
First of all, the protein surface is represented in an easier way than the full-atoms 
representation, preserving the geometrical and physicochemical properties of the 
atoms. The basic description of the protein surface is the atomic representation of 
exposed residues, which can be usually achieved by mathematical models, such as 
geometrical shape descriptors or a grid.42 The geometrical shape descriptors are 
widely used, in which each amino acid is represented by a sphere. As an alternative, a 
grid representation may be used, in which the points are calculated on the basis of 
force field potentials for van der Waals and electrostatic interactions.245 The protein 
interior, the surface and the outer space can be differentiated by the use of grid-based 
molecular representations in combination with Fourier correlation algorithms. 
Once having the easier representation of the system, almost all the docking programs 
use the same approach for the searching step: one protein is fixed in space (usually the 
bigger one) and the second one is rotated and translated around the first one. To 
minimize the degrees of freedom, both molecules are treated as rigid bodies, but still a 
simple systematic search is usually impracticable because the searching algorithm 
entails evaluating in the order of billions (109) distinct possibilities.60 
Although geometric complementarity of the protein surface is the filtering criterion 
most commonly used to eliminate a large number of solutions with poor surface 
matching,47 the docking problem is not simply matching two irregular shapes, but 
there are also other geometric, electrostatic or hydrophobic factors to take into 
account.61 So, there are a lots of possible search methods that have been used in 
protein-protein docking programs. Most methods that perform well in CAPRI (see 
Chapter 1 and paragraph below) are based only on two approaches. These approaches 
are rigid body exhaustive search, involving Fast Fourier Transforms (FFT) and Monte 




Fast Fourier Transform 
The Fast Fourier Transform (FFT) correlation approach, introduced in 1992 by 
Katchalski-Katzir and co-workers,62 revolutionized rigid body protein-protein 
docking. The basic idea of the method is to represent one of the proteins (which will 
be identified as the receptor) on a fixed grid, the second protein (which will be 
referred to as the ligand) on a movable grid, and consider an interaction energy 
written in the form of a correlation function (or as a sum of a few correlation 
functions).246 Since such energy functions can be efficiently calculated via Fast 
Fourier Transforms, it is possible to exhaustively sample the conformational space of 
protein-protein complexes evaluating the energies for billions of conformations on the 
grids, and thus to dock proteins without any a priori information on the expected 
structure.50,247 The original scoring function, introduced by Katchalski-Katzir et al.,62 
accounted only for shape complementarity, but was later extended to include 
additional terms representing electrostatic interactions,53,248 or both electrostatic and 
solvation contributions.79 Since the FFT correlation method performs exhaustive 
sampling on a dense grid, it necessarily samples near-native conformations, 
independently of the shape of the energy surface. Anyway, as said before, even if 
correct solutions are generated, scoring functions often fail to rank them properly, so 
the structures that are close to the native conformation do not necessarily have the 
lowest energies. 
 
Monte Carlo method 
While the rigid body search based on FFT is global but has to rely on simplified 
energy functions defined on a grid, the Monte Carlo analyses involve more detailed 
energy functions and more thorough searches, possibly accounting for side chain 
flexibility. However, Monte Carlo is a statistical method, and due to the improved 
energy evaluation, the Monte Carlo based algorithms (such as the ones at the basis of 
RosettaDock64 and ICM81 docking programs) requires extensive calculations, and the 
simulations can explore only limited regions of the conformational space on 
reasonable time scales. Although the Monte Carlo minimization (MCM) trajectories 
can move ”uphill” and thus cross energy barriers, there is no guarantee that the search 
converges to the global minimum. In fact, the Monte Carlo based docking methods 
include a first stage that uses simplified protein models and energy functions to 
explore the conformational space, and only then switch to simulations that involve 
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models with more detailed geometry and more accurate energy functions. Thus, 
results provided by Monte Carlo minimization may heavily depend on the initial 
points of the simulations. For this reason, quite often this method is preceded by a 
perturbation of the ligand’s position by random translations and rotations.  
 
Scoring and ranking docking decoys 
After a first low-resolution search step, a high-refinement scoring step is required to 
evaluate the energies of protein-protein docking poses in order to identify the one 
with the lowest energy as the predicted binding mode.47 Docking algorithms can be 
classified on the basis of the position of the scoring phase in the algorithm flow, into 
two groups: integrated and edge functions. In integrated algorithms, scoring is 
integrated into the search stage and is thus used to filter emerging solutions. In edge 
algorithms, scoring is applied at the end of the search stage. The major difference is 
therefore that the scoring function is part of the design of the binding solutions in 
integrated algorithms, but not in edge algorithms.42 
The fundamental point of any docking method is to be computationally efficient, 
having a scoring scheme able to evaluate a huge number of solutions and discriminate 
the native-like binding modes from the wrong decoy complex structures in a 
reasonable computational time.42 Most of the docking algorithms developed so far use 
the extent of geometric complementarity of the protein surfaces as an initial filter to 
eliminate a large number of solutions with poor surface matching. It is, however, 
usually recognized that a criterion based exclusively on geometric complementarity is 
far from being enough to distinguish among native and non-native docked geometries, 
except for a very a small number of cases.67 Numerous criteria have been 
implemented with different levels of success: steric complementarity of the shapes of 
the interaction sites, electrostatic interactions, hydrogen bonding, van der Waals, pair 
potential, desolvation, rotamer probabilities, contact pair potential and knowledge-
based potentials. Different docking programs can use different combination of this 
terms in a weighted sum. Furthermore, exclusion of the solvent from the interface and 
the associated solvent entropy change play an important role in the stabilization of 
protein interactions, and can be estimated from empirical potentials or database 
derived functions.18,68  
Resuming the docking procedure and scoring, the initial searching step yields a long 
list of candidate structures; the following step requires some forms of post-processing, 
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which may include: i) scoring or re-scoring of the docked conformations using a more 
accurate energy function, or ii) refining the conformations followed by re-scoring and, 
eventually, clustering.74 These treatments usually improve the number of near-native 
conformations among the 10 to 100 lowest energy structures, but in most cases are 
unable to eliminate all false positives.  
 
The flexibility problem 
One of the most important difficulties in protein docking is that the interface residues 
of both interacting molecules may undergo a conformational change on complex 
formation. Although often the conformational change is limited to side-chains, a 
comparison of bound and unbound structures from PDB34 reveals significant changes 
also in backbone conformation upon binding.249 In protein-protein docking, because 
of the large number of atoms and degrees of conformational freedom involved, it 
would be impracticable to treat molecular flexibility in an explicit way with the 
current available computers, so flexibility is still the major challenge in protein-
protein docking in terms of computational time.250 
Since it is infeasible to explore all possible conformations, protein flexibility is 
introduced into docking protocols only in some steps, and in a variety of ways. As it 
is not feasible to execute extensive conformational searches during docking, unless 
the binding site is known, it has been generally adopted the two-stage approach. 
Initially the interacting molecules are treated as rigid bodies and a fully exploration of 
the six-dimensional rotational and translational space is made. At a second stage, a 
much smaller number of structures acquired in the initial stage are refined and re-
ranked by more scrupulous energy functions that include small backbone and side-
chain movements as well as rigid-body adjustments to take into account 
conformational changes.79 Quite often among docking programs, both backbone and 
side-chain flexibility are being introduced using molecular dynamics (MD) in 
combination with some form of rigid-body docking, either before or after the MD 
simulations.33,251 
In addition, the backbone flexibility can be modeled implicitly as a pregenerated 
ensemble of rigid structures generated from the unbound structure. The ensembles can 
be achieved by using different solved experimental structures from X-ray or NMR 
studies of diverse conformations of the same protein. If the experimental ensembles 
structures are not available, MD and Monte Carlo simulations have been used to 
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generate full protein ensembles and so to incorporate protein flexibility in docking 
(but only for small-scale movements).46,252 
In alternative, normal-mode analysis can also be used to calculate the normal modes 
that are related with the flexibility of the protein and therefore may be used to model 
large global motion.253 Is this way, only backbone motions are studied because the 
model used to calculate the normal modes considers C-alpha atoms only.254 
In addition to inducing flexibility in the backbone, also the side-chain flexibility has a 
fundamental role and it can permit an efficient docking if some interfacial residues are 
in incorrect conformation.39 In 1994 Totrov et al. published one of the first successful 
ab initio predictions of a complex that combined pseudo Brownian Monte Carlo 
minimization with a biased-probability global side-chain placement procedure. They 
showed that side-chain optimization was fundamental for discrimination of near-
native conformations from false positives.255 
The majority of the docking methods adjust side chain conformations explicitly 
during a refinement stage following the rigid-body search, which is characteristically 
performed only for a selected set of protein side chains close to the putative binding 
site and side chain conformations are represented as a discrete set of rotamers from 
libraries. These libraries are derived from statistical analysis of side-chain 
conformations in known high-resolution protein structures.256 In fact, the 20 amino 
acids do not show the same degree of freedom. Amongst the protein complexes, 
arginine, lysine, glutamate and methionine present the highest frequency and 
amplitude of movements between the structures of free and co-crystallized proteins. 
257 In contrast, many of the smaller polar or charged residues, such as asparagine, 
aspartate and histidine, and the large aromatics, phenylalanine, tyrosine and 
tryptophan, are markedly inflexible. So, for example, the lysine side chains flex 25 
times more often than do phenylalanine side chains.253,258-260  
 
Critical Assessment of Prediction of Interactions (CAPRI) 
A variety of approaches have been used in docking programs have that mostly differ 
in the stages of the algorithms, showing different performances depending on the 
approach and the nature of the biological system. In this scenario, the comparison of 
different docking programs to establish their relative performances is very important. 
Indeed, it is required an objective valuation of the model quality. To this aim, the 
international Critical Assessment of Prediction of Interactions (CAPRI) experiment 
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was designed, precisely to evaluate current computational approaches of protein–
protein docking (details in Chapter 1).75  
To assess the quality of the models in CAPRI, after a least-square superimposition of 
the receptor in the model and target, three aspects are analyzed:  
1. the RMSD distance Lrms between Ca atoms of the ligand (L) in the model and 
target;  
2. the interface RMSD distance Irms, calculated with the Ca’s of the epitopes 
only;  
3.  the fraction of native contacts fnc = nc/Nc, where Nc is the number of residue 
pairs in contact in the target, and nc the number of those native contacts that 
are present in the model.  
These parameters Irms, Lrms, and fnc are then combined to classify and rank the models 
in correct and incorrect ones. In models of the ‘‘high-quality’’ and ‘‘medium’’ 
categories, fnc is higher than 0.3, Irms is lower than 2 Å and Lrms is lower than 5.0 Å. 
Models with 10–30% of the native contact pairs and Irms between 2 Å and 4 Å, are 
placed in the ‘‘acceptable’’ category. Although their geometry is poor, they should 
still be useful for site-directed mutagenesis and other experiments, because a large 
part of the epitopes must be correctly identified to yield fnc >= 0.1.Table 14 
summarizes the criteria available for ranking the CAPRI predictions.68 
 
 
Table 14. Criteria for ranking CAPRI predictions. 
 
Four of the most common docking programs are RosettaDock,64 ZDOCK,79 
HADDOCK32 and ClusPro.56 The present different advantages and disadvantages 








RosettaDock64 starts with a step in which the position of the ligand is perturbed by 
random translation and rotations. Next, a fast Monte Carlo minimization optimize the 
complex orientation with respect to features that do not depend on the explicit 
conformations of the side-chains (e.g. amino acid propensity at the interface, amino 
acid pair preferences, etc;64). After this step, explicit side chains are added back  
using a backbone-dependent rotamer packing algorithm and an all-atom optimization 
locates the local minimum energy conformation. No filters are applied to filter out 
promising models; in fact, the sampling problem is attacked creating a very large 
numbers of poses (decoys), which are then discriminated using a detailed scoring 
function including van der Waals and solvation interactions, hydrogen bonding, 
desolvation energy, residue-residue pair statistics, rotamer probabilities and a simple 
electrostatic term across the interface.261 While the weights of most of the terms in the 
scoring function are of the same order of magnitude, the dominant contributions to 
discrimination are the van der Waals (packing) interactions, followed by solvation.64 
In this procedure, no backbone flexibility is allowed. Decoys are then ranked and 
clustered. To select final models, the decoy with the highest score is selected for each 
of the top ten largest clusters. 
Predictions are usually performed without including any a priori biological 
information, being the energy of a model the primary criterion for the selection of the 




ZDOCK is a rigid body Fast Fourier Transform (FFT) based algorithm. It 
exhaustively samples the rigid body mutual orientations of the docking partners79 and 
this stage could be filtered introducing biological structural information. In fact, 
ZDCOK procedure allows the definition of blocking residues (which in contrast with 
interfacial residues would be given zero desolation energy). The scoring function of 
ZDOCK is a weighted sum of energy terms representing shape complementarity, van 
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der Waals energy, Coulombic electrostatics and a simplified implementation of the 
atomic contact potential score, which essentially measure the solvation/desolvation 
function contributions to the binding free energy. A protocol on CHARMm removes 
possible clashes, optimize the polar interface and optimize the charge interaction. 
Finally, a cluster of the top predictions is performed to reduce structural redundancy.  
 
HADDOCK 
The searching step in HADDOCK32 algorithm starts with a randomization of the 
orientation of the two interacting molecules, followed by a rigid body docking and 
energy minimization. After this step, in which the two proteins are treated as rigid 
bodies, there is a semirigid simulated annealing in torsion angle space, and a final 
refinement in Cartesian space with explicit solvent. During the last two steps, the 
amino acids at the interface (both side chains and backbone) are allowed to move to 
optimize the interface packing.32 The filtering applied in the searching stage take in 
account experimental information. In fact, an HADDOCK’s peculiar approach is the 
possibility to use biochemical and/or biophysical interaction data, such as chemical 
shift perturbation data resulting from NMR experiments or mutagenesis data, to 
reduce the conformational search space and filter the solutions. In particular, the most 
fundamental differences in comparison with other algorithms is that HADDOCK 
translates information about the interface into highly ambiguous inter-molecular 
distance restraints used to directly drive the docking process.32,262 
Flexibility is introduced at several levels in the algorithm: in the searching stage, it is 
introduced by docking from ensembles of structures (coming from experimental data 
or short MD simulation in explicit solvent263) and taking all possible pairwise 
combinations and by introduction of flexibility in the side chain at the interface; 
instead, at the final refinement stage the algorithm allows both side chains and 
backbone flexibility by simulated annealing MD and steepest descent minimization.  
The final structures are clustered using the pairwise backbone RMSD at the interface 
and they are scored as a sum of electrostatic, van der Waals, electrostatic, buried 
surface area, desolvation energy and Ambiguous Interaction Restraints (AIR) that are 
derived from any kind of experimental information available concerning the residues 
involved in the inter-molecular interaction.32 Recently, explicit inclusion of interfacial 
water was incorporated in the docking protocol and incorporated in CAPRI 




The ClusPro56 is a fully-automated docking program that includes three main steps. 
First, it runs PIPER, a rigid body docking program based on the Fast Fourier 
Transform (FFT) correlation approach. The major advantage of PIPER is the 
inclusion of pairwise interaction potentials.246 The top 1000 structures are retained 
from PIPER to the second step consisting in clustering.57 The clustering of the 
retained conformations is based on the pairwise RSMD of ligand structures, 
calculated for the atoms that are within 10 Å of any atom of the fixed receptor. It uses 
a simple greedy algorithm to find the structures with the largest number of neighbors 
within a clustering radius RC. The choice of RC depends on a clustering parameter 0 
≤ Δ ≤1, which is based on the histogram of pairwise RMSD values, and measures the 
depth of the separation between clusters. Once a clustering radius RC is selected 
(default value of 9 Å), the structure with the highest number of neighbors within RC 
is considered as the center of the first cluster and is the representative structure for the 
cluster. The members of this cluster are removed, and the algorithm selects the next 
structure with the highest number of neighbors from the remaining ligands until the 
set is exhausted, thereby generating 10 to 30 rank ordered clusters.57 The 30 largest 
cluster centers are then subjected to a straightforward (300 step and fixed backbone) 





The success of docking algorithms has consistently improved over the last years, as 
measuring by the CAPRI blind docking experiment. Due to such efforts, on one hand 
the applicability of in silico created complexes is becoming widly accepted, and on 




The aim of my PhD work has been to provide novel computational instruments and to 
give useful insight into one of the most crucial topics in nature: the protein-protein 
interaction (Chapter1). 
In particular, my research has been devoted to two main aspects: i) the development 
of new methods to analyse protein complexes, and to compare and rank multiple 
docking solutions (Chapters 2, 3 and 4), and ii) the application of these methods, in 
combination with classical state-of-art computational biology techniques, to predict 
and analyse the binding mode in real biological systems, which are related to 
particular diseases. The second part of the work has been afforded in collaboration 
with experimental groups (Chapters 5, 6 and 7), in order to take advantage of specific 
biological information on the systems under study. 
 
Part 1: development of new methodologies 
Due to the importance of protein-protein interactions, the interest in their structural 
characterization is constantly growing within the scientific community.1 However, 
due to the difficulty to obtain experimental 3D structures for protein-protein 
complexes, their accurate prediction through molecular docking simulations has 
become one of the major challenges in the field of structural computational biology 
and bioinformatics.2,3 Unfortunately, although success in docking algorithms has 
consistently improved over the last years,59 correctly ranking predicted models to 
single out the best ones from a decoys ensemble remains an open challenge. 
In this scenario, it is of timely interest, both for bioinformaticians and wet biologists, 
to have programs and tools able to: i) automatically analyze features of a complex 
interface, and to easily and intuitively discriminate between similar and different 
binding solutions, ii) compare multiple docking solutions, in order to appreciate at a 
glance which are the residues most often predicted as interacting and iii) accurately 
rank hundreds of docking solutions to distinguish native-like from incorrect ones.. 
On this basis, in my PhD work I developed three web tools to automatically analyze 
biological complex structures, COCOMAPS4, and to compare and rank multiple 
docking solutions, CONS-COCOMAPS5 and CONS-RANK. The web tool 
COCOMAPS (available at https://www.molnac.unisa.it/BioTools/cocomaps/, details 
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in Chapter 2) analyzes the interfaces of protein-protein and protein-nucleic acids 
complexes, combining in a single tool the traditional analysis and 3D visualization of 
biocomplexes with the effectiveness of the contact map view.  
The web tool CONS-COCOMAPS (available at 
https://www.molnac.unisa.it/BioTools/conscocomaps/, details in Chapter 3), instead, 
easily measures and visualizes the consensus in multiple docking solutions. This 
novel tool uses the conservation of inter-residue contacts as an estimate of the 
similarity between different docking solutions.  
CONS-RANK (available upon request from the authors, details in Chapter 4) is a 
simple and effective method to rank multiple docking solutions; it is well performing 
and robust, thus offering a valid alternative to the ranking methods already available.  
 
Part 2: study of protein-protein interactions in real biological systems 
Firstly, I studied two cases of biological complexes involved in the celiac disease; 
both studies were afforded in collaboration with the group directed by Prof. Daniele 
Sblattero, University of Piemonte Orinteale (Italy) and the group directed by Prof. 
Carla Esposito, University of Salerno (Italy).  
In the first study (Chapter 5), I performed docking simulation to obtain the molecular 
model for a biological complex involved in the celiac disease, made up by celiac 
autoantibodies isolated from celiac patients, and its auto-antigen Tissue 
Transglutaminase type 2 (TG2).7,154 
In the second study (Chapter 6), instead, I performed docking simulation and the 
following analysis to the complex between the celiac autoantibody Ab1-clone 2.8 and 
the mouse anti-idiotype antibody Ab2-AIT2 elicited against Ab1. These 
investigations provided useful insight into orientation and characterization of the 
complexes’ binding site. 6  
Due to the crucial involvement of the complex TG2-antoantibody and the idiotypic 
network in the celiac disease causes, the diagnosis applications and the promising 
therapeutic applications, the proposed models could help rationalizing the 
experiments as crucial step for the study of the celiac disease mechanism, the 
improvement of diagnosis strategies and the rational design of molecules for 
pharmacological and therapeutic purposes.267 
In addition, I worked on a project regarding a pathogenic mutant of the enzymatic 
system FXa, that causes problem in the process of blood coagulation, taking 
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advantage of the computational molecular dynamic technique.8 The study was 
afforded in collaboration with the Prof. De Cristofaro’s group, Catholic University 
School of Medicine, Rome (Italy) and the group directed by Prof. Peyvandi, Ospedale 
Maggiore Policlinico and Università degli Studi di Milano (Italy). 
This study can help the emergence of new therapeutic products for the treatment of 
coagulation deficiencies (for details see Chapter 7) 
 
 
Visiting PhD at University of Oxford 
Finally, during my PhD I spent seven months in the groups of the Prof. Charlotte 
Deane, Department of Statistics, University of Oxford (UK). In that period, I studied 
the geometrical features of the proteins’ regions most recurrent in the protein-protein 
interaction, the loops, clarifying some structural aspects of them in one of the most 
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